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(i)
a b s t r a c t
Gram-negative bacteria contain lipopolysaccharide, a 
toxic and highly biologically active component of the outer 
cell wall. Of the three regions of lipopolysaccharides, the 
hydrophobic portion, lipid A, is biologically active, toxic, 
and immunogenic. Here investigations into the nature of the 
immunodominant structure of lipid A were carried out.
The antigen, lipid A of Salmonella comprises a 
diglucosamine backbone substituted with ester-bound 
^14' ,hydroxy-C^^-and amide-bound hydroxy fatty acids.
Initially purification by electrodialysis, polyamine removal 
and thin layer chromatographic 'heterogeneity' was investigated 
in order to obtain a serologically homogeneous preparation.
The specific immune globulin fraction was isolated 
from whole immune serum by an immune absorbent CT^lumn of 
lipid A-bovine serum albumin.
With this purified antigen and antibody, serological.' 
assays were adapted to this hydrophobic antigen. These 
included immune precipitation, passive haemolysis, enzyme- 
linked immunosorbent assay (ELISA), complement fixation 
and the inhibition of each respective assay. Liposomal 
incorporation increased antigenicity and aided solubility of 
the hydrophobic antigen which was otherwise highly susceptible 
to non-specific interaction with ions, proteins, etc.
With these tools, degradation of the antigen was 
carried out by treatment with acid ( removal of KDO),alkali 
(removal of ester-bound fatty acids) and hydrazine (removal 
of ester-bound and eventually, amide-bound fatty acids).
(ii)
Using 30 min hydrazinolysate fractions containing amide- 
bound fatty acid, glucosamine and phosphate with high 
serological activity were obtained. Further treatment with 
immobilised alkaline phosphatase did not reduce this activity 
whereas it was lost by further hydrazine treatment, 
proportionally to the loss of hydroxy-C^^. The diglucosamine 
backbone (20 h hydrazinolysate) was inactive, as was the 
acetylated diglucosamine.
Preliminary results indicated that the amide-bound 
hydroxy-C^^ substituted glucosamine was still as mitogenic 
as lipid A but displayed reduced toxicity.
In summary, this study indicates a role of an amide-
bound fatty acid ( hydroxy-C^^) substituted on the 
glucosamine backbone in the immunodominant structure of 
lipid A.
(iii)
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CHAPTER ONE INTRODUCTION
1.1 Gram-negative bacteria
Bacteria have been divided into two main groups 
according to their ability to take up the Gram stain: 
Gram-positive and Gram-negative bacteria.
In many animal species including man, Gram-negative 
bacteria are responsible for a significant proportion of 
infectious diseases like Salmonellosis, Shigellosis and 
Cholera. Certainly, surface components play a important 
role in the interaction between bacterial cell wall and the 
host.
The following figure (Figure 1) shows a schematic 
representation of the enterobacterial cell wall. It 
consists of the inner cytoplasmic membrane, the murein net, 
and an outer membrane containing lipopolysaccharide, 
phospholipids and proteins. Of these, the lipopolysaccharides, 
especially those of Salmonella and Escherichia coli, have 
been studied most extensively.
—  Lipopolysaccharide, 
-T Proteins
j-L ip id  bi layer,
Phospholipids
Lipoprotein
—  Murein
—  Cytoplasmic
Membrane
Figure 1. Section through the Escherichia coli cell wall 
(Braun, 1971.)
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1.2 Lipopolysaccharides
Lipopolysaccharides are the 0 antigens of Gram-negative 
bacteria. At the same time they are the endotoxins responsible 
for the endotoxic activities associated with Gram-negative 
infections.
The lipopolysaccharides are visualised as being 
positioned within the outer membrane anchored by aid of the 
lipid component, designated as lipid A, with the polar 
portions of the molecules extending from the cell surface 
(Romeo, et al, 1970). Free lipopolysaccharide is obtained 
by extraction of bacteria with phenol-water (Westphal, et 
al, 1952). Their general structure has been evaluated in 
the past.
1.2a General Structure of Lipopolysaccharides
Lipopolysaccharides derived from a large number of 
different Gram-negative micro-organisms are made up according 
to a general architecture. Three distinct structural parts 
may be recognised, the 0-specific polysaccharide, the core 
polysaccharide and a lipid , the lipid A.
O Polysaccharide. The 0-specific polysaccharide is made up 
of repeating oligosaccharide uni t.s^  whose structure and 
composition vary between strains of a genus. It determines 
the serological specificity of the lipopolysaccharide and 
of the bacterial strain from which it derives.
Core Polysaccharide. The structure and composition of the 
core polysaccharide is less variable and seems to be similar 
for species of a genus. In Salmonella it is present as a 
branched polymer containing glucose, galactose, N-acetyl- 
glucosamine and unusual sugars such as heptose and 2-keto- 
3-deoxyoctonate (KDO), (see Figure 2).
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Some constituents are substituted by phosphate and ethanolamine 
The core is linked to lipid A through 2-keto-3-deoxyoctonate.
NAcClcN«N*Acrtyl Glwcosomine 
GW" Glucose 
Gcl-Gdoctose 
Hep » Heptose
KDO -2 - heto - 3 - deoiyoctonflte
0 -S P E C IF IC  CHAIN CORE LIPID A
Figure 2, Schematic representation of Salmonella Lipopolysaccharii 
(Modified from Rietschel, et al, 1975)
Lipid A . Lipid A is a common constituent of the lipcpolysaccharidi 
whose structure and composition seem to be similar, if not 
identical, in- Enterobacteriaceae. It contains a phosphorylated 
hexosamine disaccharide backbone, 4-phospho-glucosaminyl-0-l, 
6-glucosaminyl-l-phosphate, substituted at position three of 
the non-reducing glucosamine by the core polysaccharide. The 
amino groups carry 3-hydroxymyristic acyl residues. The hydroxyl 
groups are esterified with lauric ( dodecanoic), palmitic 
(hexadecanoic) and 3-myristoxymyristic (tetradecanoic-oxy-tetra- 
tetradecanoic) acyl residues.Several lipid A units may be 
polymerised by polyvalent cations, like Mg or Ca, or polyamines. 
The formula of lipid A is shown in Figure 3.
-4-
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Figure 3. Lipid A of Salmonella lipopolysaccharide with KDO 
trisaccharide~ (Modified from Rietschel, et al, 1975j.
Ester-linked lauric, myristic and palmitic acid and 
amide-linked 3-hydroxymyristic acid have also been found to 
be present in the lipid A of other bacterial genera such as 
Serratia, Aerobacteria, Citrobacter, and Escherichia 
(Alaupovic, et al, 1966j Gallin and O'Leary^ 1968; Koeltzow 
and Conrad, 1971; Ikawa, et al, 1953; Burton and Carter, 1964; 
Taylor, et al, 1966; Mc'Intre, et al, 1967; Rooney and 
Goldfine, 1971). However, the 3-hydroxymyristic acid does not 
appear to be an obligatory constituent of lipid A and examples 
have been found where it is either absent or replaced by other 
3-hydroxy fatty acids. Thus two Brucella species were found to 
contain no hydroxy fatty acids (Lacave, et al, 1969; Berger, 
et al, 1969), while in Pseudomonas aeruginosa and Pseudomonas 
alcaligenes it is replaced by 3-hydroxydodecanoic acid (Fensom 
and Gray, 1969; Hancock, et al, 1970; Roberts, et al, 1967).
1.2b Rough (R) Mutants
Mutant strains, R mutants, defective in the synthesis of 
lipopolysaccharide have been isolated from many Gram-negative
— 5 —
bacteria. They synthesise incomplete lipopolysaccharides, 
which lack the 0-specific chains and contain the complete 
core, or only fragments of the core linked to lipid A.
The classes of R mutants so far known are designated Ra to • 
Re. Ra mutants synthesise a complete core. Re mutants 
contain the most defective lipopolysaccharide with only 
KDO and lipid A ( see Figure 4).
Mutants defective in the synthesis of KDO are not 
viable under normal growth conditions. Lehmann, et al, (1977)
O -polysacchoride  
( repeating un its  ) core polysaccharide
e
Lipid  A
N  □  E
S -  Lipopolysaccharide
 ^ L ip id  A SR-Lipopolysaccharide
C  "  N-ocetylgUico$omin#
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CD “ heptos»
SZ “ KDO 
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Lip id  A
r
g— I Lipid A
Lipid A
— Glc -  Gal -  Glc -  Hep
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Hep -  KDO -  KDO —
—  Lipid A
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Rd,
Rd;
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Figure 4. Schematic representation of the structure of S 
and R form lipopolysaccharide. (Modified from Galanos, 1975)
however, reported recently the isolation of temperature- 
sensitive lipid A mutants. At elevated temperatures of 
cultivation these mutants stop growing, but for one generation 
they synthesize , an incomplete lipid A. Chemical analysis 
revealed that this lipid A lacks KDO and the non—hydroxylated
— 6 —
fatty acids, and contains only the hydroxy fatty acids 
linked to the phosphorylated glucosamine backbone ( compare 
with Figure 3)(Lehmann, 1977).
1.2c Isolation of Lipopolysaccharides
The most common method for lipopolysaccharide extraction 
is the phenol-water procedure (Westphal and Lüderitz,1952) 
because of its wide range of applicability. It involves 
heating the dried bacteria in an aqueous mixture of .45% 
phenol at 6 8°C. On cooling,the monophasic mixture separates 
into a water phase containing mainly lipopolysaccharide 
and a phenol layer containing proteins.
Galanos, et al, (1969) developed a new method
of extraction, applicable to the more hydrophobic lipopoly­
saccharides. This method uses phenol-chloroform-petroleum 
ether (2:5:8 by volume) and is specific for the isolation 
of R-form lipopolysaccharides. After extraction in phenol- 
chloroform-petroleum ether, the chloroform and ether are 
removed by evaporation and the lipopolysaccharide is 
precipitated from the phenol phase by addition of water.
1.2d Preparation of Lipid A from Lipopolysaccharide
Mild acid hydrolysis of lipopolysaccharide cleaves the 
acid-labile linkage of KDO to lipid A. Therefore treatment 
in 1% acetic acid liberates "free lipid A" from lipopoly­
saccharide. It is obtained as an insoluble precipitate free 
of polysaccharide components.
1.3 Physicochemical Properties of Lipopolysaccharides and 
Lipid A
Lipopolysaccharides, due to the presence of the lipid
— 7—
A, form large aggregates in aqueous solutions. Sodium
deoxycholate or Tween have been used to disperse lipopoly­
saccharide or lipid A, (Niwa, et al,1969).
Lipopolysaccharide are negatively charged due to the 
presence of phosphate and carboxyl groups. In the isolated 
form, these groups are neutralised by metal cations and 
polyamines such as Na^,K^.Ca^^,Mg^^, ethanolamine, putrescine, 
spermine and spermidine.
Removal of these basic substances has been achieved 
by electrodialysis. This method enabled the preparation 
of lipopolysaccharides in the free acid form and their 
subsequent conversion to uniform salt forms by neutralisation 
with different bases. Lipopolysaccharides show different 
properties depending on the particular salt form. The / 
triethylamine form, for example, has a low sedimentation 
coefficient with low aggregation and is one of the most 
soluble forms. On the other hand, the calcium form has a 
high sedimentation coefficient displaying high aggregation 
and partial insolubility.(see Table 1 ).
Table 1; Sedimentation Coefficients of Various Salt Forms 
of lipopolysaccharide. (Modified from Galanos and Lüderitz, 
1975)
S value of lipopolysaccharide from 
Preparation S.minnesota R595 (Re mutant)
Original lipopolysaccharide 78 
Original lipopolysaccharide 78 
with triethylamine 
Triethylamine salt form 10
Pyridine salt form 24
Ethanolamine salt form 26
Sodium salt form , 104
Potassium salt form 110
Putrescine salt form 149
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Thus electrodialysis enabled the preparation of 
lipopolysaccharide in the free acid form (Galanos and 
Lüderitz, 1975 ) and their conversion to uniform salt forms 
which represent better defined homogeneous derivatives with 
more predictable physicochemical properties.
Lipid A, prepared from lipopolysaccharides by acid 
hydrolysis, is insoluble in water. Like lipopolysaccharide 
it may be converted to the free acid form by electrodialysis 
and rendered soluble in a fixed salt form by the addition 
of bases such as triethylamine.
1.4 Biological Activities of Lipopolysaccharides
Lipopolysaccharides, due to their exposed position on 
bacterial cell wall surfaces, play a significant role in 
infection and are responsible for many of the typical physio- 
pathological reactions. Many of the pathological, toxic 
reactions expressed by endotoxin can be related to the lipid 
A moiety. It has been shown that lipid A is the active 
principle of lipopolysaccharide. Biological activities exhibited 
by free lipid A include lethal toxicity, pyrogenicity 
complement activation, adjuvance activity and B-lyrphocyte 
mitogenicity. Table 2 shows the wide diversity of biological 
activities of lipid A in the higher organism. Some of these 
will be discussed in more detail below.
1.5 Lipid A as the Endotoxic Principle
In 1952, Westphal and Lüderitz postulated that lipid A 
is the biologically active part of lipopolysaccharides, being 
responsible for the biological activity of lipopolysaccharide 
in animals. This hypothesis was based on the following evidence: 
Firstly, R mutants were isolated, whose lipopolysaccharides, 
although carrying incomplete polysaccharide, nevertheless
Table 2. Biological Activities of Lipid A
Pyrogenicity (Galanos, et al, 1972; Rietschel, et al, 1973.) 
Lethal toxicity in mice (Galanos, et al, 1972 )
Leucopenia (Corrigan and Bell,-. 1971 )
Local Shwartzman reaction (Galanos unpublished )
Bone marrow necrosis (Yoshida, et al, 1972)
Abortive activity in mice (Galanos, et al, 1977)
Embryonic bone resorption (Hausmann et al, 1970, 1972).
Complement activation (Galanos and Lüderitz, 1976)
Depression of blood pressure (Westenfelder, et al,1975)
Platelet aggregation
Hageman factor activation (Morrison and Cochraine, 1974) ■
Induction of plasminogen factor activation (Gordon, et al,1974)
Limulus lysate gelation (Yin, et al, 1972)
Toxicity enhanced by BCG (Galanos, et al, 1977)
Toxicity enhanced by adrenalectomy (Galanos, et al, 1977)
Enhanced dermal reactivity to adrenaline (Neter and Ribi,1963)
Induction of tolerance to endotoxin (Rietschel, et al,1973)
Induction of non-specific resistance to infection (Galanos,et al,
1977)
Induction of early refractory state to endotoxin pyrogenicity, 
Adjuvance activity (Andreesen, 1974)
Mitogenic activity for cells (Janossy, et al,1973; Andersson,et
al,1973; Rosenstreich, et al,1973; 
Bona, et al, 1975 )
Tumour necrotic activity (Kasai, et al, 1961; Parr, et al,1973) 
Macrophage activation (Alexander and Evans, 1971)
Induction of colony stimulating factor (Apte, et al,1975;
Eaves and Bruce, 1974) 
Induction of IgG synthesis in newborn mice (Kolb, et al, 1974) 
Induction of prostaglandin synthesis (Dey, et al, 1974,1975) 
Induction of interferon production (Schiller, et al, 1976) 
Induction of tumour-necrotising factor (Green, et al, 1976;
Carswell, et al,1975) 
Type-C RNA virus release from mouse spleen cells (Moroni,et
al,1975, Moroni and Schumann, 1975,1976, 
Philips, et al, 1976)
Induction of mouse liver pyruvate kinase (Smith and Synder,1975)
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exhibit full biological activity. Secondly, lipid A, 
complexed with inert carriers, produces soluble forms of 
lipid A which carry full biological activity (Galanos, et 
al,1972). Further evidence was obtained by electrodialysis, 
whereby soluble lipid A in uniform salt forms was prepared 
and could be tested without the use of solubilising carriers.
It was found to be as active as intact lipopolysaccharides 
in many different biological systems.
1.5a Lethality
Susceptibility to the lethal effects of endotoxin varies 
greatly among different species, rabbits being very susceptible 
and mice relatively resistant. The nature of the intestinal 
flora appears to affect susceptibility. The lethal toxicity 
of endotoxin is increased by a factor of 1000 in mice treated 
with Bacillus Calmette-Guerin (BCG),(Chedid, et al,1971).
The lethal toxicity of endotoxin is also significantly 
enhanced by prior adrenalectomy, the sensitivity being higher 
by a factor of about 10^. The increased sensitivity is related 
to the absence of steroids, mainly corticosteroids, and is 
reversible by the administration of cortisone
1.5b Pyrogenicity
Temperature regulation is affected in most animals by 
endotoxin. Depending on the animal species the result may 
be either hyper- or hypotî-ermia. Man is probably the most 
sensitive of all animals, responding with marked fever to 
submicrogram amounts of endotoxin. AnMals such as horses, 
rabbits, cats and dogs show a similar response. The pyrogenic 
response in rabbits is dose-related with a biphasic rise in 
temperature.For example, an intravenous injection of O.Olug/kg 
lipid A leads to a biphasic fever response with maximum
-11-
temperatures one and three hours later.
The time lag between endotoxin injection and the onset 
of fever is about 15-30 min in rabbits and 45-90 min in man, 
suggesting an indirect mode of action mediated by endogenous 
pyrogen. This endogenous pyrogen, a low molecular weight protein, 
is believed to be released from stimulated granulocytes, 
macrophages and Kupffer cells.
1.5c Tumour Necrosis
The regression or haemorrhage of tumours induced by bacterial 
products, in particular endotoxin,(Coley's toxins ) was described 
as early as 1893 (Coley, 1893). In the 1930's it was noted 
that endotoxin fails to kill tumour cells in vitro. Necrosis 
was therefore considered to be due to an indirect effect of 
endotoxin. The tumour-necrotic effect of endotoxin ^  vivo 
has been extensively documented (for example, Ikawa, et al 
1952, 1953,1954 ) yet the mechanism of action has not been 
identified.
115d~Mitogenic Activity
Lipopolysaccharides were shown to be mitogenic for bone- 
marrow derived (B) lymphocytes of mice,(Andersson, et al,
1973), guinea pig lymphocytes, chicken fibroblasts. (Vaheri, 
et al, 1973) and dog kidney cells (Westenfelder and Galanos,
1974). Mouse spleen B lymphocytes are stimulated by 
lipopolysaccharide to increased DNA and protein synthesis 
and protein secretion. Like all other biological activities 
this is also dependent on the lipid A part of the lipopolys- 
accharide molecule (Andersson, et al,1973). B cells of other 
animal species (such as humans, rabbits, monkeys and rats) 
respond only weakly to lipopolysaccharide treatment. Moreover, 
lipopolysaccharides have no effect on B cells of
-12-
the endotoxin-resistant C3H/HeJ mouse strain (Sultzer and 
Nilsson, 1972; Sultzer and Goodman, 1976; Skidmore, et al,
1975; Morrison and Dotz, 1976). These mice, however, show high 
mitogenic responses to other constituents of the Gram-negative 
bacterial cell wall, such as lipoprotein and possibly other 
proteins (Melchers, et al, 197T) .
1.5e Shwartzman Reaction
The Shwartzman reaction, haemorrhagic necrosis, can be either 
a local, dermal reaction or generalised. The dermal Shwartzman 
reaction is initiated by a preparing injection of endotoxin 
into the skin of a rabbit, followed 2 4 hours later by a provoking 
intravenous injection. Within 2-6 hours haemorrhagic necrosis 
can be observed at the site of intradermal innoculation.
The generalised Shwartzman reaction is induced by two intravenous 
injections of endotoxin carried out 2 4 hours apart. It is 
characterised by extensive internal haemorrhagic lesions 
specifically, severe necrosis of the kidneys and, depending 
on the amount of endotoxin injected, the animals may die.
The Shwartzman reaction may also be induced by free lipid 
A. Soluble lipid A, in the triethylamine salt form was found 
to induce both the local and generalised Shwatzman reaction 
with an activity comparable to that of intact lipopolysaccharide.
1.5f Interaction with Complement
The mechanisms underlying the various activities of endotoxin 
are, as yet, unknown. The finding that interaction of lipopoly­
saccharide with complement leads to the generation of biologically 
active factors, such as anaphylatoxin, chemotactic factors, 
and the activators of the clotting system have suggested a 
central role of complement for many endotoxic activities.
Complement is a multicomponent system of serum proteins
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which are present in normal serum in a non-active state.
Activation of complement occurs by two independent pathways.
The first, the 'classical pathway' is mediated by antigen-
antibody immune complexes involving all complement components.
Lipopolysaccharide however, can also activate complement by
the 'alternate pathway' i.e. it is able to activate directly
independently of the presence of C^,C^, or antibodies. This
pathway involves only the complement components to (see
Figure 5 ) . The property of lipopolysaccharide to interact with
Complement (C) Activation
-► Cq
Serum Factors
I
CLASSICAL PATHWAY ALTERNATE PATHWAY
Antigen/Antibody complex LPS_
Zymosan 
Dextran 
Cobra Venom
Biological
Activities
Anaphylatoxin 
Chemotactic Factor ,
Platelet Aggregation ;
Blood Pressure Depression ■
Figure 5. The Two Pathways of Complement Activation.
complement leading to a loss of haemolytic activity is referred 
to as anticomplementary activity.
Most lipopolysaccharides interact with complement only
when present in a state of aggregation. This could be tested 
when electrodialysis of lipopolysacccharide and their conversion 
into defined salt forms had been introduced. Low molecular 
weight triethylamine forms and high molecular weight sodium 
forms have been compared and only the latter ones exhibited 
anti-complementary activity.
Lipopolysaccharides do exist which have either low or 
no anticomplementary activity. In this case the absence of 
anticomplementary activity is an intrinsic property of the 
lipopolysaccharide and is not dependent on molecular weight.
It is noteworthy that lipid A preparations from all 
lipopolysaccharides, active and inactive ones, do carry high
-14-
anti complementary activity, again showing that lipid A is 
the biologically active centre of lipopolysaccharide.
1.6 Ir.Tmunogenic Properties of Lipid A
1.6a Lipid A as Immunogen
. Lipid A is an unusual antigen due to its lipidic character. 
Although lipidic antigens exist, for example, the phosphatides 
and sphingolipids, brain lipids, Forssman hapten and tumour 
antigens (Rapport and Graf, 1969) , the antigenic determinants 
are usually associated with non lipidic parts of the molecule 
i.e. oligosaccharides.
When whole bacteria, or isolated lipopolysaccharides, were 
injected into experimental animals, antibodies,directed 
exclusively against the polysaccharide portion were produced.
In contrast, antibodies to the lipid A portion were not found. 
The low immunogenicity of lipid A as part of the lipopoly­
saccharide seems to be due to a masking effect of the 
polysaccharide. Also, in its native form on the bacterial 
surface, the lipid A is embedded within the bacterial cell 
wall and, unlike the polysaccharide, is not sufficiently exposed 
to act as a strong immunogen. A method of producing 
substantial quantities of anti-lipid A antibodies was developed 
(Galanos, et al, 1971). Lipid A was made immunogenic'by 
exposing it on the bacterial cell surface; this was carried 
out according to the scheme shown in Figure 6. The treatment 
of Re mutant cells with 1% acetic acid for 1-2 hours at lOO^C 
leads to the cleavage of the KDO moiety, whereby the lipid 
A on the cell is exposed. Such acid-treated cells induced the 
production of anti-lipid A antibodies in a variety of animals. 
Their immunogenicity could be improved by coating these acid- 
treated cells with additional free lipid A. Specific anti-lipid
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Figure 6. Preparation of ImirunogQiiic Lin id A. (Galanos, et al,1971}
A antibodies can thus be stimulated which are detected by the 
passive haemolysis assay. This test utilises the lysis of 
lipid A coated erythrocytes in the presence of specific 
antibodies and complement.
Natural antibodies with lipid A specificity have been detected 
in the serum of various species including man, rabbits, goats 
and rats. Anti-lipid A activity is increased significantly in 
patients with Gram-negative infections, particularity with 
urinary tract infections (Westenfelder, et al ,1977). It has 
been*postulated (Galanos, et al, 1977) that during infection 
the lipid A moiety may become exposed on the bacterial cell.
1.6b Immunogenicity of Lipid A in Various Animal Species
After a primary immunisation with lipid A vaccine anti­
lipid A antibodies are induced in rabbits, goats, dogs, rats, 
vervets and baboons. After boostering, a significant increase
in circulating antibody occurs within two weeks._________    __
It was originally thought that mice were unable to respond 
to lipid A immunisation. Recently, however, it was shown
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(Freudenberg and Galanos, 1978) that the time intervals for 
immunisation require special adaptation in order to achieve 
antibody production in mice. High titres could be induced when 
the period between the first and second immunisation was greater 
than three weeks. Within one or two weeks, the titres sharply 
reach a maximum and again decline. This unusual behaviour of 
mice requires further investigation because mice are the most 
commonly used animals for studying the various biological 
activities of endotoxins.
1.7 Tolerance
Tolerance against the pyrogenic action of endotoxins has 
been classified into two types. The first type, actively-induced 
tolerance, is induced by repeated injections of lipopolysaccharide 
or lipid A and is thought to result in the generation of anti-lipid 
A antibodies (Kim and Watson, 1966). The second type, early 
refractory state tolerance, is induced following a single injectioi 
and is maximal within 24 hours. Fever tolerance is thought 
to be mediated by similar mechanisms and can be transferred 
by IgM antibodies.
1.8 Biological Significance of Anti-lipid A Antibodies
1.8a Protective Effect of Anti-lipid A-Antibodies in Infection
Conflicting results appear in the literature with regard 
to the ability of antiiipid A antibodies to protect mice 
against Gram-negative pathogens. Some authors observed no ' 
protective effect, for example, Hodgin and Drews,(1976) found 
no protection in mice with the Re lipopolysaccharide or lipid 
A to Escherichia coli challenge (also Mullan, et al, 1974).
Using a special immunisation schedule in mice ( see above) 
(three weeks interval between the first and second immunisation) 
Galanos, et al (1977) achieved a 40-60% survival following
infection with Salmonella typhir.iuriurn. With supplementation 
of the animals with fresh rabbit serum (providing an active 
complement haemolytic system which normal mice lack), a 
protection of approximately 100% could be obtained.
1 ■ SH Ot-hsr Effects of Antl-lipld A Antibodies
Anti-lipid A antibodies have been shown to opsonise
Escherichia coli 0111 iui vitro for intraperitoneal
phagocytosis in mice. Opsonisation v/as also shown with killed
51Salmonella enteriditis bacteria, labelled with Cr, by 
measuring the clearance from thé blood into the liver.
Anti-lipid A antibodies suppress lipid A and lipopoly- 
saccharide-induced skin necrosis Shwartzman reaction in rabbits. 
Furthermore, anti-lipid A antibodies specifically mediate a 
reduction of lipid A induced fever in rabbits previously exposed 
to lipid A. Similarily, lipid A-induced leucopenia, again in 
lipid A-pretreated rabbits, could also be partially inhibited 
by antirlipid A antibodies.
1. 8c Damaging Properties of Anti-lipid A antibodies
Lipid A antibodies can also cause unwanted effects. They 
are thought to be involved in lipid A-induced tissue damage.
Lipid A injected into the renal pelvis of adult dogs induced 
an abacterial interstitial nephritis in some dogs (Westenfelder 
and Galanos, 1974). This nephritis was only observed in those 
animals which were capable of responding immunologically to 
lipid A, and indicates the involvement of antilipid A antibodies.
1.9 Detoxification of Endotoxin
The mechanism of detoxification of endotoxin vivo 
is unclear; it may be associated with the cellular compartment 
or with the blood plasma compartment, or both. Plasma
”18“
carboxylic esterases, which are organophosphate-tesistant, 
were claimed to bind and inactivate endotoxin. Esterases 
isolated from spleen and granulocytes may function to 
inactivate cell-bound endotoxin. The mechanism of tolerance 
may result from increases in the concentration of these esterases 
but this has yet to be established.
I.IQ Relation of Structure to Biological Activity of Endotoxin
Acidic and alkaline degradation have been used in an attempt 
to isolate the active principle of endotoxin.
1.10a Effect of Alkali Treatment
With free lipid A, mild alkali treatment (5 min in 0.25 M 
NaOH at 56^C) results in the loss.of myristoxymyristic acid.
After longer treatment ( 60 min) approximately 50% of the ester- 
linked fatty acids are lost (Rietschel ,et al,1972;Neter, et al,1956 
Neter, et al, (1956) reported that short periods of alkali 
treatment increase the erythrocyte modifying capacity of lipid 
A without altering its antigenicity, toxicity or pyrogenicity. 
Alkali treatment for longer periods neither affects the 
erythrocyte modifying capacity of lipid A nor its antigenicity, 
but does reduce its toxicity and pyrogenicity. Possibly the 
loss of ester-bound fatty acids and the opening of groups by 
alkali treatment enables lipopolysaccharide to attach better 
onto erythrocytes, fix proteins, antibodies etc.
Mitogenicity was also thought by many authors to be affected 
by alkaline treatment of lipopolysaccharide (Peavy, et al,1973;
Poe and Michael, 1976; Andersson, et al,1973: Von Eschen and 
Rudbach,1976; Niwa, et al, 1969: and Neter, et al, 1956). These 
studies will be discussed in more detail later.
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1.10b Effect of Acid Treatment on the Biological Activity of 
Lipopolysaccharide.
on acetic acid hydrolysis of lipopolysaccharide the acid- 
labile KDO-lipid A bond is disrupted and free lipid A is 
released. Although this may result in a loss of biological 
activity, there exists overwhelming evidence today that the 
reduced biological activity that crude acid hydrolysates show 
is mainly due to the partial insolubility of the resulting 
lipid A.
1.11 Synthetic Lipid A Analogues.
In addition to degradation reactions, identification of 
the structures in lipid A responsible for biological activity 
have also been carried out using synthetic lipid A structures 
Synthetic lipid A analogues such as palmitoyl-D-glucosamine 
have been found to be mitogenic for mouse B lymphocytes with 
an activity half that of the wild-type S lipopolysaccharide 
(Rosenstreich, et al, 1974). This glucosamine derivative was 
inactive in the Shwartzman reaction, mouse lethality and 
pyrogenicity tests. N-myristoylrD-glucosamine and N-decanoyl- 
D-glucosamine, both resembling structures in the lipid A 
molecule, were found to give radiation protection.
1.12 Biological Activity of the Lipid A Precursor.
The biosynthetic precursor of lipid A containing 
phosphorylated diglucosamine partially substituted with 
B-hydroxymyristic acid and lacking non-hydroxylated fatty 
acids and polysaccharide,( as outlined earlier) has also 
been useful by providing natural partial structures of 
lipid A for biological tests.
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1.13 Object of the Present Thesis
The importance of lipopolysaccharides and their manifold 
modes of action in many animal species including man has been 
outlined.
The development of endotoxin research, as detailed in 
this chapter illustrates the importance of the toxic ( and 
an immunogenic) principle of lipopolysaccharide, namely lipid
Of lipopolysaccharides', the most thoroughly studied species 
are those derived from Escherichia coli and Salmonella which 
are representative of Enterobacteracea. Studies on Salmonella 
have the added advantage in that mutants have been isolated 
which contain lipid A with KDO trisaccharide and varying amounts 
of core polysaccharide and 0 polysaccharide. The lipid A of 
Salmonella is particularily interesting since it appears to 
contain the structure common to all Enterobacteracea. Salmonella 
lipid A show complete immunological cross-reaction. For these 
reasons Salmonella lipid A represents the most suitable model 
for chemical and biological investigations.
Since the discovery of anti-lipid A antibodies by 
Galanos, et al (1971), approaches involving the study of the 
in vitro interaction of the lipidic antigen with these antibodies 
were undertaken. In particular, the question concerning the 
Immunodominant region of the lipid A molecule, its structure 
and reaction with the specific antibody became of special 
interest. The present paper describes the development of 
serological assays for lipid A-anti-lipid A and their use in 
the elucidation of the imniunodeterminant structure of lipid 
A by stepwise degradation and serological analysis of lipid 
A.
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CHAPTER TWO 
PREPARATION AND PURIFICATION OF LIPID A
2.1 Introduction
Smooth form lipopolysaccharides, as well as defective 
lipopolysaccharides belonging to the various (R) classes, 
are present on the outer cell wall of Gram-negative bacteria 
and may be isolated by a variety of procedures.
Since free lipid A is not a precursor of lipopolysaccharide
the sole source of free lipid A is intact lipopolysaccharide
from which it can be set free by mild acid hydrolysis.
Lipopolysaccharides and lipid A contain divalent cations and 
polyamines neutralising the acidic groups of the molecule 
and leading to random cross-linking of molecules. These basic 
substances may be removed from lipopolysaccharide by 
electrodialysis, a method used extensively in the present 
study.
In this section, chemical analysis of the constituents
of lipid A, namely glucosamine, phosphate and fatty acids
including 2-keto-3-deoxyoctonate (KDO) for Re lipopolysaccharide 
will be described. In the present study the results of 
fractionation of lipid A by thin layer chromatography are 
presented. The chemical composition of the fractions will 
be considered and related to their antigenic activity in 
order to find out whether or not the antigenic activity of 
free lipid A is evenly distributed within a preparation.
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2,2 Preparative Mëthods
2.2a Bacterial Culture
Cultivation of S and R form bacteria was carried out under 
controlled conditions of temperature, pH and aeration, as 
described by Schlecht, et al, (1968) and harvested at late 
log phase. The bacteria were killed with phenol, centrifuged 
at 15,000 rpm and washed successively in water, water-ethanol 
(1:1), absolute ethanol and acetone. They were finally dried 
in a vacumn desiccator and stored until use.
The composition of the lipid A and the core portions 
of lipopolysaccharides was reported by Fromme and Schlecht,(1973 
to be widely independent of the cultivation conditions, unlike 
their 'O' polysaccharide portion whose length may vary under 
different conditions.
The extraction of lipopolysaccharides from S bacteria was 
carried out by the phenol-water method (Westphal, et al, 1952) 
that from R form bacteria by the phenol-chloroform-petroleum 
ether method (Galanos, et al, 1969).
2.2b Phenol-Water Extraction of Smooth Form Bacteria
Dried bacteria (50g) were incubated with 700 ml water and 
700 ml 90% phenol for 5 min at 69*^ C. The mixture was cooled 
in ice and centrifuged (15 min, 2,000 rpm). The water phase 
was collected and the phenol phase extracted once more with 
water. The first and second water phases were pooled and 
dialysed, concentrated to 10 ml, and centrifuged (three 
times, 100,000 g , 4 h). The lipopolysaccharide pellet was 
lyophilised. (Yield was approximately 3% based on dry weight 
bacteria).
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2.2c Phenol-Chloroform-Petroleum Ether Extraction of Rough 
Form Bacteria
This extraction procedure was used extensively in this 
study particularily with the Re mutant R595 which represents 
a rich source of lipid A. The dried bacteria were suspended 
in a mixture of phenol (90 g in 11 ml water), chloroform and 
petroleum ether (b.p. 40-60°C) in a volume ratio of 2:5:8. 
Suspension was aided by short homogenisation ( approx. 30 
sec) with a cooled Potter homogeniser. After centrifugation 
the sediment was re-extracted twice. From the pooled 
supernatants chloroform and petroleum ether were expelled in 
a rotary evaporator (40°C). To the remaining phenol, water 
was added dropwise until the lipopolysaccharide precipitated, 
It was centrifuged, washed twice with 75% phenol and thrice 
with acetone. The dried material was dissolved in distilled 
water and centrifuged (100,000 g for 4 h). The sediment was 
re-dissolved in distilled water and lyophilised. (Yield 
approximately 5.5%).
2.2d Electrodialysis of Lipopolysaccharide^
Lipopolysaccharide preparations contain divalent ions, 
such as Mg^^, Ca^^ and basic amines, such as spermine, 
spermidine,cadaverine, putrescine and lysine. Their presence 
affects the biological and physicochemical properties of the 
lipopolysaccharide and the lipid A derived from it. The aim 
of electrodialysis is to remove first this mixture of ions 
and then replace them by a single ion.
Electrodialysis of lipopolysaccharide was carried out 
by the method of Galanos, et al (1975) in an apparatus 
containing three chambers separated by dialysis membranes 
(visking tubing), with electrodes in the outer chambers and
the lipopolysaccharide in the middle. '
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The pH (7.2) was kept constant by continuously neutralising 
with 2N NaOH the central chamber which was also cooled by 
cycling cold water through. The contents of the outer chambers 
were renewed twice an hour. Dialysis was stopped when the 
cathode chamber no longer became alkaline (after a few hours 
at 40 mA), neutralisation with NaOH was stopped and the pH 
allowed to fall. The resulting lipopolysaccharide, now present 
in the free acid form (denoted as LPS-free acid form), was 
converted to a water-soluble form by neutralising with alkali 
or amines, such as triethylamine.
2.2e Preparation of Free Lipid A
Electrodialysed R595 lipopolysaccharide (Re mutant, 0.8 g 
dry weight) was hydrolysed in 80 ml of 1% acetic acid at lOO^C 
for 90 min (Osborn,1963;Risse, et al, 1967). After centrifugation 
the water insoluble, free lipid A was washed once with 20 ml 
of hot 1% acetic acid, twice with cold O.IM HCl, once with water, 
and lyophilised (Yield approximately 25%). The lipid A (2mg/ml 
in water) was neutralised with triethylamine to pH 7.2 (0.4pl 
per 2 mg) with sonication and gentle warming to solubilise.
Earlier studies by Volk, et al, (1970) revealed that many 
lipopolysaccharides contained a rare amino sugar, 4-amino-4-L- 
deoxyarabinose. During acid hydrolysis, degradation of this 
amino sugar takes place with the concomitant development of 
a brown colour leading to a dark brown coloured lipid A 
preparation. N-acetylation of the free amino-group renders the 
amino sugar in the lipopolysaccharide stable to acetic acid 
hydrolysis and the brown colour is not developed.
2.2f N-Acetylation of R595 Lipopolysaccharide
Acetic anhydride and saturated sodium bicarbonate solution 
(667 \il and 13.4 ml respectively) were added every 15 min
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for 1 h 30 min to Salmonella Minnesota R595 lipopolysaccharide 
(2 g dispersed in 133 ml water) with sonication (Redmond,J., 
unpublished). The solution was then dialysed, concentrated, 
freed of cations by electrodialysis and lyophilised. Free lipid 
A was prepared as described above. The lipid A was converted 
into its triethylamine form. The serological specificity of 
this colourless preparation in passive haemolysis tests (see 
below) was comparable to that of the lipid A obtained from non- 
acetylated lipopolysaccharide. This indicates at least that 
degradation leading to the formation of the brown colour does 
not affect the antigenicity. In most experiments, lipid A from 
Salmonella minnesota R595 was used.
2.3 Fractionation of Lipid A
A heterogeneity of lipid A can be visualised by 
chromatography on thin layer plates (t.l.c) developed with 
organic solvents, eg. mixtures of chloroform-methanol-water.
We have used this method for preparative isolation of 
distinct lipid A fractions in order to study comparatively 
some biological properties, especially their antigenic 
properties.
The lipid A ( about 5 mg) was dissolved in the solvent 
mixture (2 mg/ml chloroform-methanol-water, 140:45:7, the 
same solvent as used for chromatography ), and applied onto a 
t.l.c plate as a line. Either commercially available 
Kieselgel 60 plates (Merck, 0.25 mm thick) or plates prepared 
with buffered silica gel (0.1) M phosphate buffer and activated 
overnight at 140^0 by the method of Wilkinson, et al,1973) 
were used. The bands were visualised with water vapour spray, 
iodine vapour, or by charring a section of the plate with 
sulphuric acid at 140°C. In general, iodine staining of the
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Figure 7.Thin Layer Chromatography of Lipid A.
Lipid A ( free acid form ) was run on silica gel plates 
in chloroform-methanol-water (140:45:7) and visualised by
charring with sulphuric acid at 140 C
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entire plate, which does not destroy the samples and acid- 
charring of one section was used. The areas corresponding 
to the bands ( see Figure 7) were scraped off into test tubes 
and eluted with solvent with slight warming, sonication and 
Vortex mixing. They were filtered through a celite column 
and the columns washed with large volumes of solvent. The 
eluates were concentrated vacuo and small samples of 
each fraction ( for example 0.1 mg) rechromatographed on 
silica plates to determine purity. As shown in Figure 7, 
a number of fractions were seen. Ten could be isolated and 
proved to be pure on rechromatography. They were designated 
F (fast), M^, and (medium) and ,82/S^/ ,S^ and 
Sg (slow) according to their Rf values. The following 
sections describe the chemical and serological analysis methods 
that were applied.
2.4 Chemical Analysis of Lipid A and Sub-fractions
2.4a 2-’Keto-3-deoxyoctonate Determination (KDO)
The absence of KDO from free lipid A preparations 
is considered a valid criterion for the absence of intact 
lipopolysaccharide. Determination of KDO was therefore 
carried out (Waravdekar and Saslaw, 1959; Weissbach and 
Hurwitz, 1959). The deoxy sugar is oxidised by periodate to 
2-formyl-pyruvic acid, which then reacts with thiobarbituric 
acid to form a chromagen with absorption maximum at 54 8 nm.
2.4b Determination of Total Phosphate
In this method (Lowry, et al, 1953) the lipopolysaccharide 
lipid A or phosphate standard is ashed for several hours in 
sulphuric acid-perchlorate. The phosphomolybdate derivative 
of the degraded material is formed and the light absorption 
is measured at 820 nm.
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2.4c Estimation of Glucosamine
Glucosamine was measured in a sample after acid-hydrolysis 
(4 N HCl, 100°C, 10 h) followed by N-acetylation according 
to the method of Strominger, et al, (1959) using the Morgan- 
Elson reagent.
2.4d Determination of Fatty Acids
Long chain fatty acids were determined by gas-liquid 
chromatography (g.l.c) of their methyl esters. The procedure 
used was a modification of the method outlined by Duron and 
Nowotny, (1963) and Metcalf and Schmitz, (1961). 
Lipopolysaccharide was treated with boron trifluoride in 
methanol (100°C) and the fatty acid methyl esters isolated 
by extraction. They were analysed in a Perkin Elmer model 
F 20 gas chromatograph. (For details see Methods Section 
pages 38,39). Heptadecanoic acid was used as an internal 
standard.
2.5 Serological Analysis of Lipid A and Sub-fractions
The fractions obtained from t.l.c of lipid A were 
analysed for serological reactivity with anti-lipid A 
antibodies in a test of inhibition of passive haemolysis.
The method involves coating lipid A onto erythrocytes, which 
subsequently lyse in the presence of specific antiserum and 
complement. The degree of lysis, or its inhibition, can 
be measured spectrophotometrically (quantitative passive 
haemolysis assay) or observed in serial dilutions (1:1) of 
antiserum in haemolysis trays (semi-quantitative). This 
test will be described in detail in Chapter 3.
2.5a Inhibition of Passive Haemolysis with Lipid A and 
Sub-fractions incorporated into Liposomes.
Liposomes, have, in the past, been used as model membranes.
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Their properties, for example, susceptibility to complement­
er antibody-dependant damage arid to antibiotics (Alving, et 
al,1969; Kinsky, 1972,1970; Kinsky, et al, 1969,1971) are 
analogous to those of natural membranes. Damage to the 
membrane in these cases could be followed by the release of 
a trapped glucose marker. Recently, liposomes have also been 
applied to the detection of antibodies in sera against lipid
antigens (Kataoka, et al, 1971 . ).a , D ,
In the present study, incorporation of lipid A into 
liposomes and their subsequent use as inhibitors of the 
lipid A-anti-lipid A passive haemolysis test has been shown 
to greatly increase the sensitivity of the assay. The fixation 
of lipid A on a lipophilic inert particle prevents the lipid 
from forming micelles, or aggregating in the presence of ions 
in serum, thus exposing a higher number of binding sites for 
the interaction with the antibody.
Incorporation of the various fractions into liposomes 
was achieved by dispersing them in a mixture of lecithin, 
cholesterol and dicetyl phosphate (2:1.5:0.22 nmoles 
respectively), details are given below.
As can be seen in Figure 7, lipid A contains at least 
ten bands on chromatography. These bands were eluted and 
the fractions analysed for chemical composition and serological 
activity. These fractions, when re-applied to t.l.c plates 
appeared to be pure. However, it was noted that, on repeated 
application, elution arid chromatography, or long stor'age, 
heterogeneity was again observed.
When the fatty acid composition of lipid A and the fraction: 
was analysed, lauric, myristic, palmitic and 3-hydroxymyristic 
acid were clearly distinguished (Figure 8). In addition 
a peak with retention time of 11.24 min was observed.
In order to assert whether this peak was due to a fatty
acid present in small quantities, a logarithmic retention 
time plot of fatty acids on the column was carried out.
C12 Lauric acid
5. 0 8
C14 Myristic acid 
11. 24 Unsaturated fatty acids or 2-hydro::ymyristic acid
C16 Palmitic acid
3-Hydroxymyristic acid
------  ="-28. 95
C17 Internal standard
Figures G.l.c of Fatty Acid Esters of Lipid A on a
Castorwax Column at 175 C
-31-
Figure 9 shows the logarithmic retention time plot of fatty 
acid esters on Castorwax columns as a function of the number
of carbon atoms. This was used to illustrate that the peak
corresponding to 11.5 min does not corrrespond to a
fatty acid as it does not show the same retention time as
that expected of a fatty acid. It was thought likely
to be due to unsaturated fatty acids.
Recent information (Bryn and Rietschel, 1978) has however 
suggested the presence in lipid A of a 2-hydroxymyristic 
acid which would correspond with this peak. At the time 
of these studies, however, the presence of a 2-hydroxy acid 
had not been elucidated and further analysis of this relatively 
minor peak çiot carried out.
?arithmic,
r é te n t io n
tine
• :• I ! j ~ •
I , J -K-l ; : .
C 12
'Nunber of carbon atons
Figure 9 Logarithmic Retention Time of Fatty Acids on 
a Castorwax Column ( at 175°C) as a Function of the Number 
of Carbon Atoms
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Table 3 Cher.ical and Serolooical Analysis of t.l.c Fractionated Linid A ( refer Fleure 7)
Lipid A Fraction, Whole
Lipid
F
A «1 "2 %3 =1 =2 = 3 =4 =5
Glucosamine (pnol/r.g) 0.72 0.018 0.55 0.055 0.23 .0.18 0.11 0.05 0.40 0.41
Phosphate (pmol/mg) 0.93 0.02 0.79 0.035 0.34 0.21 0.21 0.05 0.29 0.31
Fatty Acids (pr.ol/mg)
Lauric acid 0.07 0.07 0.003- 0.03 0.17 ,0.03 0.01 0.003 0.14 0.19
Myristic acid 0.25 0.04 0 • 0 0.11 0.03 0.04 0.004 0.26 0.35
Palmitic acid 0.30 0.04 0.013 0.07 0.20 .0.02 0.01 0.019 0 .30" 0.31
;■>. -H ■I’d r oxy r.y r i s t i c 
acid
1.13 0.01 0.092 0.31 0.73 0.07 0.11 0.066 1.11 1.47
Total Fatty Acids 
(umol/r.g)
1.76 0.15 0.11 0.42 1.21 0.14 0.15 0.09 . 1.81 2.31
Serology*(ug) 0.002 1.2 0.005 0,625 0.C05 0.019 0.039' 0.312 C.,156 0.312
*i.g cf traction required to inhibit two hacr.olytic units of anti-lipid A antibodies in the inhib iticn
passive hacr.ciynis assay.
Table 3 shows the analysis of the fractions obtained from 
t.l.c. fractionation of lipid A.
It is difficult to see a consistent relationship between 
chemical composition and the mobility of the fractions. No 
distinct differences can be seen, except that the material 
with lowest mobility (fraction S4 and S5) are supfisingly 
enriched in fatty acids, containing more than the original 
lipid A.
When inhibition of passive haemolysis was studied with 
these fractions again no relationship between chemical composit­
ion and serological properties was evident. In controls of 
amboceptor coated erythrocytes or the heterologous system of 
Salmonella abortus equi:anti-Salmonella abortus equi n o • 
interactions were shown by the fractions. Generally it appeared 
that the serological interaction with anti-lipid A antibodies 
was approximately proportional to the glucosamine content, 
although fractions Mg,S4 and Sg certainly do not conform to
this suggestion. This fraction M 3 also does not accord with 
any relationship between: phosphate content and the serological 
reactivity as shown by most other fractions. This fraction 
contains high serological activity and content of
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/3-hydroxymyristic acid, but as fractions and contain 
more of this fatty acid and show less serological interaction 
with anti-lipid A antibodies, there is no evidence for such 
a relationship.
When the fatty acid content of the fractions is considered, 
fractions and stand out as opposing the possibility of 
a relationship between fatty acid and serological activity.
A problem of poor solubility of these fractions in aqueous 
solutions was overcome by incorporating them into artificial 
membranes (liposomes) of phosphatidyl choline, lecithin and 
dicetyl phosphate, prior to use in the serological test. Table 
4 shows the results obtained from a second experiment, where 
fractionation of lipid A was carried out on t.l.c plates with 
elution of the bands. These fractions were tested for inhibition 
of passive haemolysis , directly or after incorporation into 
liposomes, as well as chemical analysis of the fractions.
Less chemical data on individual fractions is available 
in this experiment compared to Table 3 due to poor recoveries.
The serological tests, carried out directly, or with the fraction 
incorporated into liposomes, shows a significant increase in 
the antigenicity of the fractions in the latter case. When 
these results are compared with values for total fatty acids 
more evidence of a relationship is obtained. When the serological 
activities of the fractions are plotted against the contents 
of the fatty acids, the result for 3-hydroxymyristic acid compare 
closely with that of the total fatty acids ( not suprising since
it is the most abundant fatty acid in lipid A) and corresponds 
well with that of the serological reactivity of the fractions
incorporated into liposomes.
In addition another fraction with high mobility containing 
mainly free fatty acids was obtained.
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• Table 4. Further Chemical and Scrolcclcal fjialysis of t.l.c Fractionated Llolc! A, Soroloffical ir.vostleatlon 
including the 1 ncomeratier, of the Fraction: into Lioosores.
Fraction  ^ Whole
Lipid ;
"'3
Glucosamine (unol/mg) 0.72 “ " O.lO - 0.28 ' 0.09 0.03 0.02
Phosphate (nmol/mg) 0.93 “ " 0.06 - ’ 0.04 - 0.03 0.22
Fatty Acids (pmol/mg)
Lauric acid 0.74 0.26 0.29 0.54 0.02 0.06 . 0.61 0.05 0.47 1.05
Myristic acid 1.04 0.41 0.45 0.47 0.11 0.29 0.57 - 0.16 0.21
Palmitic acid 1.29 0.5 0.5 0.5 0.11 0.59 0.96 - 0.18 0.90
2-Hydrcxymyristic acid 2.72 1.44 1.34 2.2 0.34 - 1.95 0.05 0.66 2.92
Serology*
Direct (ug) 0.0015 “ “ 0.024 - ' 0.78 - 12.5 0.012
Liposomes (ug) 0.0008 0.007 0.0012 0.005 0.0097 0.078 0.0027 n.0068 0.0015 •
* wg (direct or incorporated into liposomes) of lipid A, or fractions, required to inhibit two haemolytic unit-s 
of anti-lipid A antibodies in the inhibition of passive haemolysis assay.
There are several innate problems in the t.l.c separation.
As mentioned earlier, recoveries are poor and possibly significant 
differences in dry weight determination may seriously affect the 
results obtained. This problem has been observed by several authors 
and, to datg only one study (Chen and Nowotny, 1974) has been 
reported where an attempt was made to overcome this difficulty.
This was achieved by analysing the components whilst still present 
on the gel and not attempting elution. This is theoretically 
plausible for chemical analysis when very pure gels are prepared. 
However, for the purposes of comparing serological activities with 
chemical composition it was impossible to utilise this method as 
the presence of gel would interfere with the serological assay, 
so separation from the gel is necessary.
Another problem is that the substance one elutes may not be 
identical with that present in the gel band, this could be 
minimised be eluting as thoroughly as possible under as mild 
conditions as possible.
In summary, all the fractions obtained by t.l.c separation
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of lipid A show serological reactivity and chemical differences 
(as determined by their gross content), however these parameters 
do not appear to be related. This suggests that fractionation of 
lipid A by this means will only produce low yields of serologically 
similar fractions and would not be a great help in the search for 
an immunodeterminant group in lipid A. All fractions show high 
serological activity despite differences in their chemical compositioi 
and this heterogeneity appears to be irrelevant for the purposes 
of this study. It however remains a interesting phenomena which, 
hopefully will be explained when more detailed information on the 
chemical structure and conformational changes of lipid A become 
available.
This heterogeneity of lipid A has been well documented, (Chen 
and Nowotny, 1974; Chen, et al, 1975; Gmeiner, et al, 1969; Ng, 
et al, 1974; Nowotny, 1971, Kasai and Yamano, 1964; Razuiddin and 
Kawasaki, 1976; Drewry, et al, 1973; and Schiller, et al, 1976).
To date, despite numerous studies no reason for this heterogeneity 
has been discovered. Many postulates such as number, nature and 
position of the fatty acid residues or the phosphate residues, 
or the procedures used for the extraction of lipopolysaccharides 
from bacteria, or lipid A from lipopolysaccharide, as well as the 
presence of ions such as Ca^* or Mg^^ have been considered responsible 
for heterogeneity.
In this study it was not possible to observe a relationship 
between the serological activity and chemical composition of the 
fractions of lipid A. The possibility remains however, that 
conformational differences occur (which would pass undetected in 
this test ) and could relate to serological activity, or, the 
heterogeneity could be an artifact of the t.l.c method.
The fractions listed in Tables 3 and 4 showed large differences 
in their solubility which may be a reason for the differences in
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their inhibitory activity when tested in the free solution form.
The inhibitory activity was considerably enhanced when the fractions 
were incorporated into liposomes (Table 4), all fractions being 
highly active and containing 3-hydroxymyristic acid.
On the basis of these results whole free lipid A was used in 
the following studies and prior fractionation was not attempted. 
Although heterogeneity of lipid A is apparent on t.l.c mobility 
of lipid A in hydrophobic solvents, these studies have shown that 
it does not seem to be related to the ability of lipid A to interact 
with anti-lipid A antibodies, particularily relevant to these studies 
on the immunodeterminant of lipid A.
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2.6 Details of Methods outlined in this Chapter
2.6a2-Keto-3-deoxyoctonate Determination (KDO)
Lipid A solution (50 |jg) ,lipopolysacccharide (50 pg) or 
1-10 pg of KDO was incubated for 8 min at 100°C with 50 pi 
of 0.5 M HgSO^. This causes the release of any bound KDO.
Periodic acid (50 pi of 0.1 M) was added with mixing, 
and incubated 10 min at 55^C. Sodium arsenite (200 pi of 4% 
aqueous solution) was added in 0.5 M HCl and mixed for 2 min 
at room temperature. Following this, 800 pi of freshly prepared 
0.6% thiobarbituric acid was added and incubated 10 min at 
lOO^C. In the final stage, the colour was extracted into 
butanol by the addition of 1 ml butanol-conc. HCl (95:5 by 
volume) with thorough mixing and centrifugation. The upper 
butanol phase was removed and read at 552 nm and 508 nm.
Other deoxy sugars, such as deoxyribose, have an absorption 
maximum at 532 nm, therefore the extinction was measured at 
two wavelengths to eliminate the effect of interfering sugars.
2 6b Determination of Total Phosphate
Aliquots (3 and 5 pi) of lipopolysaccharide (10 mg/ml
in water) or 1-5 pi of 0.01 M phosphate standard was added
to 100 pi of conc. HgSO^ (30.6 ml) containing 70% hydrogen
perchlorate (67 ml) and heated for one hour at 95^C to remove
any water present, and then two hours at 165°C to ash the
sample. Molybdate reagent, 1 ml, containing 1 ml of 10%
ascorbic acid, 1 ml IM sodium acetate, 1 ml 2.5% ammonium
molybdate and 7 ml water, prepared fresh, was added to the
above mixture which was kept cold in ice. The mixture was — /
incubated for 90 min at 38°C and the extinction measured at
820 nm. (NB. All glassware was thoroughly washed in
concentrated sulphuric acid and rinsed in distilled water 
prior to drying and use.J
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2,6c .Estimation of Glucosamine
Lipopolysaccharide (200 pi of 10 mg/ml in water) was 
hydrolysed for 11 h at lOO^C with 200 pi of 8 M HCl in 
sealed glass tubes. This hydrolysate, (5-7 pi) or standard 
glucosamine solution (1-10 pi) was added to 40 pi of water 
and 10 pi of saturated NaHCO^, with 10 pi of freshly prepared 
5% aqueous acetic anhydride. This was incubated for 10 min 
at room temperature, followed by 3 min at 100°C. Sodium borate 
solution (5 pi of 5% solution) was added and incubated for 
7 min at lOO^C,followed by the addition of 700 pi of Morgan 
Elson reagent ( 2 parts Morgan Elson reagent, Merck, Darmstadt, 
to 5 parts glacial acetic acid) and incubated at 37°C for 
20 min, prior to the measurement of the extinction at 585 nm.
.2.6ddetermination of Fatty Acids
Lipopolysaccharide, or lipid sample, (1 mg) was suspended 
in chloroform (150 pi) in a tapered glass tube, dried and 
200 pi of 20% BF^ in methanol (Merck, Darmstadt) added. The 
tube was sealed and heated at 100°C for 4 h. The cooled tube 
was opened and 100 pg of a C^ .^  fatty acid standard (heptadec­
anoic acid methyl ester, Carl Roth OHG, Karslruhe, Germany) 
was added, and stirred with 1 ml of saturated aqueous sodium 
chloride. Petroleum ether, '(0.5 ml, b.p. 40-60^C) was added, 
mixed, centrifuged and the ether layer aspirated. The extractio 
procedure was repeated twice and the ether phases pooled 
and dried by a gentle stream of nitrogen. The extract was 
then taken up in 30 pi of twice distilled chloroform and 
0.3 pi was used for injection with solvent flushing into 
a Perking Elmer model F 20 gas chromatograph at injector 
temperature of 250°C. The substance was separated on a 
Castorwax column ( 2.5% chromosorb, 80-100 mesh, 2 metres
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X 1/8 inch) at 175°C with nitrogen carrier gas (25 ml/min) 
with a flame ionisation detector, coupled to a print-out 
register of the g.l.c of fatty acid methyl esters obtained.
2 .6e.Inhibition of Passive Haemolysis using Lipid A and'Subfractions 
incorporated into liposomes ; Preparation of Liposomes
Lecithin (2 pmoles), cholesterol (1.5 pmoles ) and dicetyl 
phosphate(o.22 pmoles) were dissolved in chloroform. Lipid 
A or its subfractions, in a variety of concentrations, was 
added to the above mixtures in chloroform, thoroughly mixed 
and the chloroform slowly evaporated off under low vacuum.
After ensuring complete drying by desiccation over calcium 
chloride overnight vacuo, formation of liposomes was 
achieved by vigorously shaking the lipid mixture in 500 pi 
phosphate buffered saline in a Vortex mixer . for one minute 
in the presence of glass beads (0.117-0.17 mm). The liposomes 
were stored as a suspension in phosphate buffered" saline 
at 4°C until use.
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CHAPTER THREE 
IMMUNOLOGICAL ASSAY flFTHODS IHPI FMFRTFn AMD ADAPTED FOR 
STUDYING THE INTERACTION OF LIPID A WITH SPECIFIC ANTI-LIPID A 
ANTIBODIES.
3.1 Preparation and Characterisation of Anti-lipid A Antiserum.
For serological studies a purified antigen and specific 
antiserum are necessary.^nti-lipid A antibodies, employed in 
this study, were prepared by the procedure of Galanos, et al, 
(1971) by immunisation with acid-treated bacteria which are
coated with additional free lipid A.
3.1a Preparation of Lipid A Immunogen.
Salmonella minnesota R595 bacteria were cultured as described 
by Schlecht, et al, (1968), killed with phenol, and centrifuged 
at 10,000 rpm (Sorvall centrifuge) for 15 min.The cells were 
washed three times with phosphate buffered . saline, pH 7.2 
and once with 1% acetic acid, centrifuged, and resuspended 
in 1% acetic acid. They were heated at lOO^C for 90 min, 
centrifuged and repeatedly washed with distilled water until 
free of acid traces. The bacteria were resuspended in distilled 
water, lyophilised and stored at 4°c. Coating with lipid A 
was carried out by suspending the cells in distilled water 
(100 mg/ml) and mixing with an aqueous solution of lipid A in 
the triethylamine form (10 mg/ml) in a volume ratio of 1:1.
The mixture was slowly dried in a rotary evaporator at 30°C
under vacuum, resuspended in distilled water, lyophilised and 
stored at 4®C.
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3.1b Preparation of Anti-lipid A Antiserum
New Zealand white rabbits (2-2.5 kg body weight) each 
received intravenously 100, 200 , 300, and 500 pg of lipid A 
immunogen in 0.5 ml phosphate buffered saline (0.1 M, pH 7.2) 
on days 1, 4, 7, and 11 respectively. The animals were bled 
on day 16 following anaesthesia with 0.6 ml Narcoren ( 16 g 
sodium pentobarbital per 100 ml) by catheterisation of the 
carotid artery.
The blood was collected in ice-cooled tubes to avoid clotting 
and was immediately centrifuged at 4^C. The plasma supernatant 
was allowed to clot at 4*^ C for 5 h. Fibrin was removed by slowly 
winding it round tweezers and pressing against the walls of 
the tube in order to expell the serum. Any fragments were removed 
by centrifugation. With this method a completely lysis-free 
serum could be obtained.
The serum was incubated at 56°C for 30 min to inactivate 
complement and absorbed free of anti-sheep red blood cell 
activity with washed red blood cells (0.2 ml sediment /ml serum) 
at 4°C for 1 h with occasional stirring and removal of the 
erythrocyte ' sediment by centrifugation. The haemolytic titre 
was determined ( usually between 16,000 and 4,000 for both rabbit 
and goat serum by the passive haemolysis method as outlined 
in pages 49-5lThe immunoglobulin fraction was isolated from 
whole immune serum by ammonium sulphate precipitation.
In this study goat antiserum was also used. A male goat was 
injected with 2 mg of lipid A immunogen in 10 ml incomplete 
Freunds adjuvant and distributed subcutaneously in four parts 
of the body. Two months later a booster injection of 5 mg lipid 
A immunogen in 10 ml adjuvant was given in a similar way.
A year later a final booster of 5 mg lipid A immunogen in 10 ml
adjuvant was given and two weeks later the goat was killed and
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bled completely. The serum was obtained, complement inactivated 
and absorbed as outlined above. All serum was stored in 1 ml 
aliquots at -20°C, with the exception of complement ( guinea 
pig complement) which was stored in aliquots of 100 pi, 500 pi 
or 1 ml aliquots at -80°C.
3.1c Preparation of Specific Anti-.lipid A Immune Globulin Fraction
In serological inhibition assays involving soluble proteins 
or polysaccharides as antigens and relatively small partial 
structures ( the corresponding antigenic determinant) as inhibitor 
the use of whole immune serum is for most purposes adequate.
As outlined earlier, lipid A and partial structures of lipid 
A, due to their hydrophobic properties, readily complex with 
proteins or other lipids and may precipitate in the presence 
of divalent cations. Since whole serum represents a complex 
mixture of proteins, lipids, phospholipids and salts, it was 
attempted to remove these non-specific substances and to prepare 
the specific immune globulin fraction.
A batch process for obtaining specific anti-lipid A antibodies 
using erythrocytes has been developed (Galanos, et al, 1971). 
Originally formalin-treated erythrocytes coated with alkali- 
treated lipid A were used, which were incubated with antiserum.
The antibodies were regained by treatment with glycine-HCl buffer 
and neutralisation (Galanos et al, S.971) .
Formalin-treated erythrocytes on a column scale dispersed 
with cellulose were, however, found to give a low yield of 
antibodies and lysis of the erythrocytes became a problem. It 
was thus thought that a new method of stabilising erythrocytes 
and in addition, a chemically fixed lipid A-complex should be 
used.
Since lipid A is thought likely to contain free amino groups 
it seemed likely that glutaraldehyde may be a suitable reagent
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for coupling lipid A onto erythrocytes.via Schiffs base formation 
utilising these free amino groups.Using glutaraldehyde as coupling 
reagent it was thought possible that the use of lipid A- bovine 
serum albumin complexes (Galanos, et al, 1972) may provide a 
more stable immunosorbent column. Erythrocytes sensitised with 
this lipid A-bovine serum albumin were still found to be 
incompletely stabilised, as, on addition of serum, lysis was 
found to be considerable, whereas washing with buffers alone 
showed no evidence of lysis. A second glutaraldehyde treatment 
of erythrocytes at twenty times the original concentration of 
glutaraldehyde was carried out for 1 h with subsequent washing 
with phosphate buffered saline. This treatment was found to 
greatly increase stabilisation of the erythrocyte membrane without 
adversely affecting elution of antibodies. Treatment of the 
antiserum with control erythrocytes exposed to glutaraldehyde 
at these concentrations did not lead to any detectable absorption 
of anti-lipid A antibodies, indicating that the presence of 
glutaraldehyde is not retaining the antibodies by insolubilisation, 
Preparation of lipid A-bovine serum albumin column!-
Washed human erythrocyte:sediment (300 pi blood group B,Rh ) 
was suspended in 7.4 ml phosphate buffered saline containing 
1.88 mg lipid A-bovine serum albumin complex prepared according 
to Galanos, et al (1972) with 320 pi of 1% glutaraldehyde (préparée 
immediately prior to use). The suspension was stirred for 1 h 
at room temperature followed by washing of the erythrocytes 
with phosphate buffered saline. The stabilisation procedure 
was then carried out by adding the washed erythrocytes to 6.2: ml 
1% glutaraldehyde ( 20 times the original concentration) with 
stirring for one hour at room temperature, followed again by 
washing with phosphate b u f f e r e d  saline. The sensitised erythrocyte
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proved unsuitable for column application in this form, as the 
compactness of the cells resulted in a very poor flow rate.
This was overcome by dispersing the cells in cellulose.(1 part 
erythrocytes; 1 part cellulose ( fine t.l.c grade) with 2 parts 
of standard cellulose). The mixture was then poured onto the 
column (14 cm x 2.5 cm, capacity 32 ml) and washed thotoughly 
with phosphate buffered saline. Ahti-lipid A antiserum of 
known haemolytic activity was circulated ( closed cicuit) by 
a peristaltic pump through the column for 2-3 h. At various 
time intervals serum samples were removed and the remaining 
anti-lipid A activity measured. When significant 
reduction in activity was obtained the serum was collected 
and the column washed exhaustively with phosphate buffered 
saline. For example, the cycling of 24 ml of anti-lipid A serum 
through the column for 2 h (approximately one cycle) reduced 
its haemolytic titre from 1/4096 to 1/32 i.e an almost complete 
absorption of antibody (99.2%). The column was washed exhaustively 
with phosphate buffered saline ( 1 1») followed by glycine-HCl 
buffer (0.1 M, pH 2.2) for desorption of the antibodies. In 
order to minimise the dénaturation of antibody due to the low 
pH conditions the eluate was cooled in ice and immediately 
neutralised. This was carried out by allowing the eluate 
to drop directly into an ice-cooled flask and neutralised (pH 7.0) 
by placing a pH electrode in the flask connected to an automatic 
titrator. The eluate was then concentrated by negative pressure 
dialysis at 4°C followed by extensive dialysis against veronal 
buffer for 1-2 days at 4°C and the haemolytic activity measured.
By this procedure 24 ml of eluate of haemolytic activity 1/512 
was obtained. The column was regenerated by thoroughly washing 
one day and one night with glycine-HCl and a further 24 h
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with phosphate buffered saline and stored at 4 c for further 
use.
The specific antibodies obtained by this method were labile 
on storage at -20^C showing a time-dependent loss of activity 
(see Figure 10, see also Lugowski and Romanowska, 19740 . It 
was found this could be reduced by storing the antiserum in 
a lyophilised state with minimal air interface with immediate 
use after dissolving;
i
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Figure 10 Loss of Haemolytic Activity of Specific Immune Globulin 
Stored at -20°C.
The specificity of the column for anti-lipid A antibodies 
was proved by cycling an antiserum prepared against the 0-specific 
determinants of Salmonella typhimurium (.containing ho haemolytic 
anti-lipid A activity). No reduction in the original anti-. 
Salmonella typhimurium haemolytic activity was observed. Further, 
the glycine-HCl buffer (pH 2.2) eluate contained neither O- 
nor lipid A- specificity.
Quantitation of antilipid A antibody recovered from column.
A lipid A-bovihe serum albumin immune absorbent column was also 
prepared using lipid A from Escherichia coli. This species lacks
—46 —
4-amino arabinose which should be excluded as a ppssible 
immunodeterminant species. The preparation of lipid A-bovine 
serum albumin coated erythrocytes was carried out as described 
above.
Anti-lipid A antiserum (10 ml whole rabbit immune serum 
with haemolytic activity 1/16,000) was diluted in phosphate 
buffeied saline and added to the column. Cycling was carried 
out for 2-3 h, the serum eluted and the column washed with 
phosphate buffered saline. The activity remaining in the serum 
was equivalent to a reciprocal haemolytic titre of 120, i.e.
1.7% of the original activity. Desorption was then carried out 
as outlined above, the eluate concentrated and dialysed 
exhaustively against veronal buffer. After adjusting to a volume 
of 10 ml the recovered activity was equivalent to a haemolytic 
titre of 1,024. It was lyophilised and stored at -20°C.
3.Id Ammonium Sulphate Precipitation of the Anti-lipid A 
Immunoglobulin Fraction.
The immunoglobulin fraction of the immune serum was isolated 
by precipitation by ammonium sulphate ( end concentration 2M).
There is some loss of antibody and degradation of immunoglobulin 
during this procedure, but whole serum contains ions, albumin 
and other non-anti-lipid A matter with which lipid A would interact 
Anti-lipid A whole serum (10 ml) was diluted with 20 ml phosphai 
buffered saline (pH 7.2) and 30 ml of 4M ammonium sulphate 
pH 7.2 added with stirring. It was allowed to stand for 4 h 
at 4^C and centrifuged at 2,000 rpm for 30 min in the cold.
The precipitate was then dissolved in 30 ml phosphate buffered 
saline and an equal volume of saturated ammonium sulphate added, 
and the precipitation repeated. The final precipitate was dissolved 
in 10 ml phosphate buffered saline and exhaustively dialysed
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against 2 litres of veronal buffer ( for 2 days with two changes 
of outer dialysate per day). It was centrifuged (15,000 rpm 
for 15 min), millipore filtered to remove small amounts of 
insoluble material, and stored frozen (-20^0) in 1 ml aliquots.
In this form there was no significant loss of activity on storage 
over a two and half year period.
By the methods outlined anti-lipid A immune serum was obtained 
by immunisation of lipid A coated bacteria and the immune globulin 
fraction isolated by ammonium sulphate precipitation. Specific 
immune globulin fraction of anti-lipid A was obtained from whole 
immune serum by using an immunosorbent column of lipid A-bovine 
serum albumin.
The total recovery of material from the immunosorbent column 
was 15%, which means a considerable loss of activity is involved 
and the possibility remains that absorption and elution 
may be selectively isolating low affinity antibodies and that 
high affinity antibodies remain on the column resisting elution 
with acid.
The necessity of isolating specific anti-lipid A antibodies 
is clear, the modification outlined above has enabled the 
development of a relatively simple column affinity method 
which, antiserum supply permitting, could be carried out routinely 
The yields^however^ are obviously such that one must question 
the possibility of selective elution of low affinity antibodies 
and the value of an isolation procedure which produces low 
recovery. Clearly further modification of this method to increase 
yields would be of value.
—4 8—
Search for an Antigen-Antibody System Suitable for Specific 
Inhibition Tests.
Quantitative evaluation of the anti-lipid A antibodies has, 
in the past, been carried out almost exclusively by using the 
passive haemolysis assay. This technique, although adequate 
for most purposes has disadvantages in that it is unable to 
detect non-complement fixing antibody. Another problem arises 
when partial structures of lipid A are used as these structures 
are insoluble in the buffers used.These materials also interact 
with complement and are susceptible to non-specific complex 
formation.
An immunological assay was therefore sought for this unusual 
antigen, which would overcome these problems and enable a sensitiv 
quantitation of specific immune complex formation. The assay 
system described in the following chapters include (a) immune 
precipitation, (b) erythrocyte lysis (passive haemolysis),
(c) specific complement fixation and (d) the enzyme-linked- 
immunosorbent assay (E.L.I.S.A.). All these tests measure antigen- 
antibody interactions. They can be used also as inhibition tests, 
by which the inhibitory capacity of the antigens or partial 
structures of it can be determined.
3.2 Quantitative Lipid A-Anti-lipid A Immune Precipitation.
Immune precipitation is based on the principle that soluble 
antigen when incubated with its specific antibody forms insoluble 
complexes which can be isolated and quantitated by a protein 
determination. Immune precipitation of lipid A with anti-lipid 
A was carried out according to the method of Kabat and Meyer, 
(1961). A series of concentrations of lipid A ( triethylamine form 
or alkali-treated )were incubated with antiserum and the protein
in the precipitate was measured by the Lowry method (Lowry,et
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al,1951). The precipitation curves all reached a plateau and 
the characteristic 'fall o f f  usually obtained with excess amounts
of antigen was absent.
This test was investigated thoroughly, serum from which 
anti-lipid A antibodies had been absorbed onto lipid A^coated 
erythrocytes gave lower, but similar, precipitation curves 
suggesting non-specific precipitation. As a negative control 
normal serum was also tested and strong precipitation indist­
inguishable from that obtained with anti-lipid A antiserum 
was obtained.
When synthetic derivatives of lipid A were used (3-hydroxy-, 
and 3-acetoxy-,myristoyl-D-glucosamine, both in the free form 
and as bovine-serum albumin complexes),,little inhibition was 
obtained and was thought to be non-specific as the inhibition 
was not dose-dependent and very small amounts of inhibitor were 
used, also the effects of small amounts of organic solvent were 
considerable.
In view of these findings other serological assays were 
investigated for their adaptability to lipid A-anti-lipid A 
interaction.
3.3a Passive Haemolysis Test:Semi-Quantitative in Trays.
This was carried out according to the method of Neter, 
et al, (1956) and is based on the principle that antigen-coated 
erythrocytes lyse in the presence of antibody and complement.
In the semi-quantitative test lysis is easily visible in the 
V-shaped wells of the haemagglutination trays (Linbro, Titertex, 
Zürich) by the absence of cell clumping. In the passive haemolysis 
test two buffers are necessary. Phosphate buffered saline is 
used for coating the erythrocytes with antigen. This buffer
2+is isotonic for the erythrocytes and divalent cations like Ca ,
2+
Mg are absent, so*.the antigen remains soluble. Veronal buffer 
is required for the haemolysis step as it contains these ions,
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which- are required for complement activation. Details of the 
preparation of these buffers is outlined later ( see page 74) 
Coating of erythrocytes with antigen*.-
Alkali-treated lipid A (10 mg lipid A per ml 0.25 N NaOH 
at 56°C for 1 h) was used as it is more efficient in sensitisir 
erythrocytes. It has greater solubility than lipid A and is 
more easily absorbed onto the erythrocyte membrane (Neter, et 
al, 1956). Both alkali-treated lipid A and lipid A can however 
be used.
The optimal antigen concentration for erythrocyte 
sensitisation was first determined by titration against a known 
antibody concentration, from this data standard conditions 
of sensitisation were adopted. •
Sheep red blood cells were washed three times with 
phosphate buffered saline until completely free of haemoglobin 
in the supernatant. Cell sediment (200 pi of erythrocytes 
from 10 min at 2,000 rpm) was suspended in 4 ml phosphate 
buffered saline and 25 pi (2 mg/ml solution) of lipid 
A (alkali treated) was added with stirring. The cells were 
incubated at 37^C for 30 min washed three times with phosphate 
buffered saline and suspended in 40 ml veronal buffer 
to give a 0.5% suspension.
Test conditions!-
Anti-lipid A antiserum (50 pi absorbed for sheep red 
blood cell activity) was serially diluted in 50 pi veronal 
buffer. Sensitised erythrocytes (50 pi) were added followed 
by one standardised drop ( 25 pi) of diluted guinea pig 
complement ( diluted 1:10 in veronal buffer and obtained 
from the Hygiene Institute, Freiburg). The tray was gently 
agitated and incubated at 37°C for 1 h, after which the 
extent of lysis was recorded. Controls of sensitised erythrocyt
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with veronal buffer, sensitised erythrocytes with dilutions 
of antiserum, sensitised erythrocytes with complement , 
normal erythrocytes with antiserum and normal erythrocytes 
with complement* were carried out with each test.
Interpretation of results:-
For inhibition tests, the haemolysis system to be 
inhibited consisted of two haemolytic units of the antiserum 
(i.e. the pre-last dilution causing haemolysis, in general 
0.1 pi), 0.0625 pg antigen ( used for sensitisation of 
erythrocytes) and 2.5 pi of guinea pig complement per well.
3.3b Alkaline Hydrolysis of Lipopolysaccharides.
Samples of smooth form lipopolysaccharide and rough 
mutants Ra to Re as well as lipid A were tested for interaction 
with anti-lipid A antibodies in the inhibition of passive 
haemolysis assay ( as outlined above), both before, and 
after^ alkaline hydrolysis (10 mg material /0.25 M NaOH 
at 56°C for 1 h). Two samples of smooth form lipopolysaccharide 
were also treated with alkali for 0-120 min. The results 
are shown in Table 5.
In this experiment the reactivity of anti-lipid A 
antibodies with lipid A as part of the intact lipopolysaccharid 
molecule is studied. This was carried out to study whether 
lipid A in the natural situation, embedded in lipopolysacc­
haride, is able to express its antigenicity and whether 
this is changed on alkali or acid treatment. -
Treatment of bacterial lipopolysaccharides or lipid 
A with mild alkali leads to the cleavage of ester-bound 
fatty acids ( see Chapter one). This treatment also appreciably 
alters many of the biological activities resulting in extensive 
detoxification. Most smooth form lipopolysaccharides do
not exhibit inhibition of passive haemolysis of lipid A:anti-
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Table 5. Ability of S and R f s m  Lipopolysaccharides and Lipid A to 
Interact with Anti-lipid A Antibodies and the Effect of Alkali. Treatment.
(a) Smooth Form Lipopolysaccharides
Salmonella newport 
Salmonella godesberg 
Salmonella aberdeen 
Salmonella djarkarta 
Salmonella london 
Salmonella typhosa 
Escherichia coli 026 
Salmonella Uganda 
Salmonella m.ontevideo 
Escherichia coli 0111 
Salmonella abortus equi
Minimal quantity required to inhibit 
two haemolytic units of anti-lipid A.
(System as described in methods)(M
1. 
2.
2.
4.
5.
6 . 
8.
12.
25
25
25
c)
17
24
6
43
21
51
49
76
(b) Smooth Form Lipopolysaccharides after Different Times of Alkali 
Hydrolysis
Time of alkali hydrolysis 
(0.25 M NaOH at 56°C% (min)
Inhibitory activity (pg) 
Salmonella Salmonella
montevideo ' abortus equi
0 25 25
5 25 25
10 25 12.5
15 25 12.5
20 25 12.5
25 25 12.5 .
30 25 12.5
40 25 12.5
50 25 . 12.5
60 25 12.5
70 25 12.5
120 25 12.5
(c) Rough Mutants of Lipopolysaccharide
Group (Salmonella Mutant Inhibitory activity (pg)
species) Original After alkali
treatment
S.minnesota Ra 50 50
S.mihnesota Rb 50 . ! 50
S.minnesota Rc • 50 50
S.minnesota Rd 25 50
S.minnesota Rd. 50 50
S.minnesota Re 0.87 3.1
S. typhimurium Ra 50 50
S.typhimurium Rb 50 50
S.typhimurium Re 0.48 3.1
(d) Free Lipid A
Inhibitory activity (pg)
Original After alkali
treatment
S.minnesota lipid A 0.012 0.0064
Escherichia coli ;lipid A 0.012
-53-
lipid A, neither before (Table 5a), nor after (data not 
shown), alkali treatment. Nor did the samples treated for 
O - 120 min with alkali (Table 5 b), Also rough form 
lipopolysaccharides do not show significant interaction 
with anti-lipid A antibodies (Table 5 c). An exception 
is the most defective mutant , namely the Re mutant (R595) 
which consists only of lipid A plus a KDO trisaccharide 
(see Figure 4). The Re mutant is active before and after 
alkali treatment. The activity in the Re«mutant is thought 
to be due to the high anticomplementary activity of this 
material. This is supported by the fact that the activity 
in the Re mutant decreases after alkali treatment, as anti­
complementary activity is also decreased on alkali treatment. 
Free lipid A, as is to be expected, shows inhibition of 
the passive haemolysis of lipid A-anti-lipid A (Table 5 d). 
After alkali treatment the inhibitory activity is retained 
and slightly enhanced, due to the improved solubility of 
lipid A lacking the ester-bound fatty acids.
In summary, cleavage of ester-bound fatty acids by 
alkali treatment from the intact lipopolysaccharide^ (smooth 
and most rough mutants) does not lead to the exposure of 
the lipid A antigenic determinants, nor loss of determinants 
already revealed (lipid A) as measured by the inhibition 
of passive haemolysis.
3.3c Acid,Hydrolysis of Lipopolysaccharide
in order to determine whether antigenicity of lipopoly­
saccharide or lipid A is changed after acid treatment 
treatment of intact lipopolysaccharide of Salmonella montevideo 
and Salmonella abortus equi was carried out with 1% acetic 
acid at lOO^C for various lengths of time. With length 
of hydrolysis there was a corresponding increase in the 
inhibitory activity, up to a plateau ( Table 6).
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Table 6. Inhibition of Lipid A-anti-lipid A by Lipopolysaccharide 
after Different Times of Acid Hydrolysis in the Passive Haemolysis 
Test.
Time of acid hydrolysis Inhibitory activity (pg)
1% acetic acid at lOO^C; S.' montevideo S. abortus equi
(min)
O 50 50
2.5 50
5 50 0.09
9 12.5 0.05
12 3.1
15 3.1 0.02
20 1.6 0.02
25 0.4
30 0.2 Ô.05
40 0.05
50 0.05
60 0.05
As these conditions cleave the polysccharide portion at the 
acid-labile KDO-lipid A linkage it supports evidence that the 
polysaccharide moiety of the lipopolysaccharide does disguise 
the antigenically reactive site(s) in lipid A.
This becomes interesting when it is considered that anti­
lipid A antibodies are detectable in the normal serum of different 
animal species. Also normal human serum may frequently. contain 
anti-lipid A antibody activity, whose occurrence is significantly 
more frequent and in higher concentrations in sera of patients 
with Gram-negative infections. These findings indicate that 
the animal and human organisms are sensitised naturally to 
free lipid A. In view of the present result showing the absence 
of lipid A antigenic reactivity from the intact lipopolysaccharide 
it would seem that either lipid A may occur to a small extent 
in the free form in Gram-negative bacteria, or the organism 
may alter lipopolysaccharide in a form whereby the immunological 
determinants are exposed. Evidence for either assumption has 
not yet been reported.
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3.3d Quantitative Inhibition of Passive Haemolysis ;Test Tube 
Assay.
The principle of this test is identical to that of the tray 
assay (pages 49-54), it is performed in tubes and, therefore 
can be quantitatively measured by spectrophotometry.
Direct quantitative passive haemolysis was first carried out 
with titration of the antiserum and antigen to optimalise test 
conditions. It was found that 20 pg of lipid A per 50 pi 
erythrocytes were optimal for gensitisation and for this antigen 
concentration^0.1 pi antiserum (16,000 haemolytic activity) or 
4 pi of specific anti-lipid A immune globulin was required for 
80% lysis of erythrocytes. Inhibition of passive haemolysis was 
carried out using dilutions of the competing antigen preincubated 
with antiserum ( see Figure 11). The details of this procedure 
are given on pages 74 &75.
Two synthetic substances 3-acetoxy- and 3-hydroxy- myristoyl 
-D-glucosamine, resembling partial structures of lipid A, and 
the lipid A fatty acids in their free form were tested for 
interaction with anti-lipid A antibodies.
The direct passive haemolysis test could not be used since 
sheep red blood cells could not be coated with the two synthetic 
preparations. Therefore they were tested in the inhibition assay. 
As all the substances showed poor solubility in aqueous buffers, 
several solubilising systems were compared. Warming with ethanol, 
dissolving in sodium hydroxide and sonication amongst others 
were used. However on treatment in this manner they exhibited 
strong inhibition which was shown by the controls to be a non- 
specific interference , namely inhibition of the antibody or 
complement in a non-specific manner.
Inhibition of passive haemolysis was, however, thought worth 
pursuing in an attempt to overcome the solubility problems of
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20 pg Lipid A
15 pg Lipid A 
10 pg Lipid A 
5 pg Lipid A
(Amounts of Lipid A 
used for sensitising 
erythrocytes)
; f i T~;
, ”*■ ul Æntiserura.
(whole anti-lipid A serum)
Figure 11 a»Passive Haemolysis of Lipid A-Anti-Lipid A. 
Titration of Antigen (Lipid A) for Sensitising Erythrocytes
Lysis
20-
J__j:-; i : • I ■ : 1 ■ ;
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Figure 11 b. Passive Haemolysis of Lipid A-Anti-Lipid A. 
Titration of Antiserum (Specific Immune Globulin Fraction)
Lipid A
20
0.60.5: 0.3 0.4
ug Competing antigen
0.1 0.20
Figure 11 c. Passive Haemolysis of Lipid A-Anti-Lipid 
A. Inhibition by Preincubation of Antiserum with Lipid 
A, or Lipid A (alkali-treated).
lOO-i • :
..... »...
■T,-! i
^  ! : !
% Inhibition , J ,L : . T-.- : j- : -j
•
! i :
f
0.12 0.25 ng Lipid A (competing
antigen)
Figure 11 d . Inhibition of Passive Haemolysis with Lipid 
A but using Specific Immune Globulin Fraction instead 
of Whole Anti-Lipid A Serum.( Figure 11 b)
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the inhibitors. The development of liposomal incorporation (see 
page 39) overcame many of these problems of insolubility in 
aqueous solution.
The two synthetic glucosamine derivatives were therefore 
incorporated into liposomes and tested as inhibitors of the lipid 
A-anti-lipid A quantitative passive haemolysis system. Both 
derivatives in concentrations up to 10^ fold of the minimal 
requirement by the complete antigen lipid A, showed no inhibitory 
activity. This result was confirmed in several experiments using 
a variety of concentrations of competing antigen. It is concluded 
that the two synthetic derivatives do not contain an immuno- 
determinant structure recognisable by anti-lipid A antibodies. 
Other possibilities do exist, for example these glucosamine 
derivatives may become integrated into liposomes in a manner 
such that any determinants present are not exposed and their 
inability to interact in aqueous solution may be a matter of 
poor solubility.
3.4 Complement Fixation
This technique is based on the principle that antigen-antibody 
complexes fix complement, present in fresh serum, leading to 
a loss of haemolytic activity.
This test (Kabat and Meyer, 1961), has the advantage over 
passive haemolysis in that it gives a quantitative measure of 
antigen or antibody. It is sensitive and differences of more 
than 100 fold in antigenic reactivity may usually be detected.
The test can be carried out with relatively small amounts of 
antiserum. It can also be used with insoluble antigens.
The complement fixation test consists of two steps, firstly 
cuitigen and antibody are allowed to interact in the presence
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Quantity of Anti-lipid A
(a) Titration of Antiserum
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{b ) Titration of Antigen (Lipid A)
Figure 12. Complement Fixation of Lipid A;Anti-lipid A 
Dependence on Antiserum (a) and Antigen (b) Concentration
poncentration of Lipid A = 2.5 pg 
Concentration of Antiserum = 0.3 pi
Concentration of Complement = 2.3 pi
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of a fixed amount of fresh guinea pig serum of known 
haemolytic activity. Secondly, the remaining haemolytic 
activity is measured by incubating with sheep erythrocytes 
sensitised with their corresponding antibodies (anti-sheep 
haemolysin, amboceptor). The amounts of haemoglobin liberated 
from the lysed cells can be measured spectrophotometrically 
and the degree of lysis is a measure of the amount of unused 
complement. The details of this method are described on 
pages 75-76 •
From the antiserum and antigen titration curves 
(see Figure 12), 2.5 pg lipid A and 0.7 pi of antiserum 
were chosen for standard conditions. These amounts, in 
the presence of 7 pi (1:3 prediluted) guinea pig serum, 
fixed about 80% of the complement haemolytic activity.
The above system proved successful and reproducible.
Inhibition studies however were disappointing because 
both the glucosamine derivatives and the free fatty acids 
displayed marked anti-complementary activity in the 
concentrations used. This was shown be preincubation of 
the derivative with complement and addition to amboceptor 
coated sheep red blood cells. For this reason the test 
was not pursued further.
3.5 The Enzyme-Linked Immunosorbent Assay (E.L.I.S.A.)
This is a micro-serological assay described by Engvall 
(1975) and Engvall and Perlmann, (1971, 1972) and developed 
as a complement to radioimmunoassay. This method has extensiv 
applications and the principle is as follows.
Antigen ( in this case lipid A) is physically absorbed 
onto an inert surface, the walls of a polypropylene tube.
Incubation of the washed test tube with specific antibody 
enables the formation of immune complex directly on the 
test tube. The amount of complex is however below the 
detection sensitivity of most assays so a multiplication 
step is introduced by further incubation of the washed 
complex with anti-immunoglobulin coupled to alkaline 
phosphatase. The alkaline phosphatase serves as a simple 
sensitive assay system, using the substrate p-nitrophenyl 
phosphate which has a molecular extinction coefficient of
approximately 17,000 at 400 nm and enables a quick relative 
determination of the amount of immune globulin present. The 
following figure (Figure 13) shows a simplified scheme of 
the E.L.I.S.A. assay.
(a) Coating of the tubes with lipid Ac-
Previous studies (Catt and Tregear , 1967) had 
indicated that the use of high pH was optimal for antigen 
binding, and similarity in the lipid A system this was 
found preferential, a pH of 9.6 was adopted for coating. 
Various types of tubes and incubation volumes for antigen 
coating were also compared, and various means of surface 
area modification by physical or chemical means( for example 
etching with fine beads, chloroform etching, amongst others). 
Optimal coating was however achieved with untreated 
polystyrene tubes ( 7.5 cm x 1 cm) by incubating 10 ng 
of lipid A (alkali treated)in sodium carbonate buffer 
(pH 9.6) for three hours with agitation. The tubes were 
then emptied, and washed with phosphate buffered saline 
containing 0.05% Tween 20 in order to remove excess non- 
bound or weakly-bound antigen. Under these conditions about 
1 ng of lipid A was fixed onto the test tube. This was 
measured by the incubation of thymidine-^H labelled lipid 
A under identical conditions.
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(a) Antigen coated 
onto tubes.
(b) Incubation with 
Antiserum
Xc) Incubation with 
Enzyme Labelled Anti- 
IgG.
(d) Estimation of 
Enzyme present.
3h 
37® C
<— Antigen |
6h
.at
37°C
#
16 h
at
37°C
<■
< — Antibodies'
Enzyme-labelled ^
Antiglobulin
E
-E
Enzyme Substrate EH
□
Amount of hydrolysis» amount of antigen present
Figure 13. Simplified Scheme of the F.L.I.F.A. Indirect 
Method.
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(b) Incubation with antiserum;-
The lipid A coated tubes were then incubated with ten 
haemolytic units of anti-lipid A antiserum in 1 ml of phosphate 
buffered saline for 6 h at 37°C with agitation.They were 
subsequently washed three times with phosphate buffered saline 
containing 0.05% Tween.
(c) Incubation with enzyme-coupled anti-lgG:-
Anti*igG conjugated to alkaline phosphatase (1/200 in phosphate
buffered saline containing Tween) was added to the washed
o
tubes and incubated overnight with agitation at 37 C. They 
were subsequently washed three times with phosphate buffered 
saline containing Tween and once with phosphate buffered. saline 
alone.
(d) Estimation of enzyme present
P-nitrophenyl phosphate (1 mg) in 1 ml of 0.05 M sodium 
carbonate containing 0.01 M MgClg, pH 9.6 was added and the 
enzyme reaction monitored by measuring the extinction 
periodically over a 2-3 h time interval. The enzyme reaction 
is, in theory, linear up to a extinction of 1/0 at 400 nm.
(e) Preparation of goat anti-rabbit IgG-alkaline phosphatase 
con jugate
The IgG-alkaline phosphatase conjugate was prepared as 
follows. Anti-rabbit whole serum was obtained by immunising 
a goat with rabbit serum. The antiserum obtained was precipitatec 
with ammonium sulphate as outlined earlier and the IgG fraction 
was separated on a Sephadex G200 column and stored at 0°C.
The IgG fraction of anti-rabbit serum was coupled to alkaline 
phosphatase via glutaraldehyde [probably due to Schiffs base 
formation (Onkelinx,et al, 1969), although some Michaels additioi 
occurs (Richards and Knowles, 1968)]. The alkaline phosphatase 
supplied as a precipitate in 2.5 M ammonium sulphate (Sigma)
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was centrifuged for 15 min at 2,000 rpm in the cold and the
pellet added to the IgG fraction in a ratio of 5:3 mg protein
respectively. Dialysis was then carried out overnight at 4°C
against phosphate buffered saline to remove unwanted ions.
Glutaraldehyde ( a 25% microscopy purity solution, diluted
to a 1% solution prior to use) was added to a final concentration
of 0.2%. The concentration of glutaraldehyde was found to be
critical as otherwise insoluble precipitates form. After stirring
for 2 h at room temperature to allow coupling to occur, extensive
dialysis against phosphate buffered saline at 4°C was used
prior to the dilution of the conjugate in 5% bovine serum
albumin in 0.05 M Tris HCl (pH 8.0) containing 0.001 M MgClg
and 0.02% sodium azide to stabilise the conjugate during 
ostorage at O C. Conjugate prepared in this way (2 ml) contained 
an equivalent of 500 pg alkaline phosphatase and 300 pg IgG 
with 20 units of enzyme.
For the E.L.I.S.A. test the optimal and most economical 
concentrations of antigen, antibody and coupled enzyme-anti- 
IgG conjugate were ascertained in titration experiments (Figure 
14). The optimal quantity of antigen was 20 pg of lipid A 
(alkali-treated) with an antiserum dilution of 1/100 and conjugate 
dilution of 1/5 00. Under these conditions a variety of . 
concentrations of enzyme substrate were used. As the results 
in Figure 14 (d) show, the concentration of substrate is not 
limiting between 0.5 mg and 5 mg and a concentration of 1 mg/ml 
was adopted for further studies.
3.5.1 Inhibition of E.L.I.S.A with fatty acids and synthetic 
derivatives
Inhibition of E.L.I.S.A. was used as experiments using 
free fatty acids (lauric, myristic, palmitic and 3-hydroxymyristic 
acid) and the glucosamine derivatives (N-3-hydroxy- and N-3-
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Figure 14. Enzyme-linked Immunosorbent Assav (F.L.I.S.A.). 
Titration of Antigen (a), Antiserum (b), Anti-IgG-Alkaline 
Phosphatase (c) and Alkaline Phosphatase Substrate (d) to 
obtain optimal test conditions for characterisation of the 
Lipid A-Anti-lipid A-Anti IgG immune complex formation.
Antigen, Lipid A (alkali treated) 20 ug (coated on tubes) 
Antiserum, Antilipid A antiserum diluted 1/100 
Anti-IgG (Anti-goat serum) diluted 1/500 
Enzyme substrate (p-nitrophenol phosphate) 1 mg/ml.
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acetoxy -myristoy1-D-glucosamine in the direct E.L.I.S.A. 
were negative.
Thèse substances were preincubated with anti-lipid A 
immune globulin fraction ( which provided a more sensitive 
assay system than using whole anti-lipid A serum) and the 
remaining free antibody in the supernatant was measured by 
adding it to lipid A coated tubes. W&ph lipid A was tested 
under these conditions a characteristic inhibition curve was 
obtained (Figure 15). With the fatty acids however at 
concentrations of 1-10 pg inhibition was also observed, this 
was followed by a loss of inhibition at higher concentrations. 
The inhibition at low concentrations was reproduced in several 
experiments, even with fatty acids not present in lipid A.
It seemed likely that this was a non-specific reaction and 
comparison was carried out with normal serum, specific anti­
lipid A immune globulin fraction and whole anti-lipid A serum. 
The fatty acids were also tested in a heterologous E.L.I.S.A 
system, that of Salmonella abortus equi:anti-Salmonella abortus 
equi. In all cases the same inhibition curves were obtained.
The reason for these unusual, non-specific inhibition curves 
is not known. It is unfortunate, especially sinde the E.L.I.S.A 
is such a sensitive system which was adapted to the lipid A; 
anti-lipid A system with success. However, its use for the 
purpose of elucidating the nature of the immundominant structure 
by inhibition with partial structures of lipid A is limited.
CO
40
0 8 10 ug Lipid A
Figure 15, Inhibition of E.L.I.S.A. with Lipid A.
Antigen on tubes Lipid A(alkali treated) 20 pg.
Competing antigen Lipid A(alkali treated) preincubated with 
1 ml of 1/25 specific immune globulin fraction of anti-lipid 
A (Titre 1/256). Concentration of enzyme linked conjugate =
1 ml of 1/500.
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3.6 Discussion
Lipid K, and in particular the synthetic lipid A model 
substances used in this section exhibit poor solubility in 
aqueous milieu, a property which prevents optimal antigen- 
antibody bonding. Good solubility is necessary for the 
serological assays used. The solubility of lipid A could 
be increased by using a low molecular weight form of lipid 
A such as the triethylamine salt, and avoiding crude preparations 
which exhibit a high molecular weight and are often insoluble 
due to the presence of divalent cations such as calcium and 
magnesium.
A characteristic property of lipid A is its ability to 
attach onto cell membranes which makes possible the coating 
of erythrocytes with lipid A and thus provides the basis for 
several sensitive immune assays such as haemagglutination and 
passive haemolysis. The ability of lipid A to absorb onto 
erythrocytes can be increased by partial removal of ester-bound 
fatty acids through alkali treatment. This increased affinity 
for membranes may be worth noting as material lacking ester- 
bound fatty acids will be discussed later in particular with 
reference to biological activities mediated by membrane . 
interactions.
The serological assays adapted for use with lipid A antigens 
will be considered in turn. Quantitative precipitation can 
be applied to measuring lipid A:anti-lipid A interactions but 
non-characteristic patterns with broad plateaus instead of 
peaks are obtained at optimal antigen and antibody concentrations 
This could indicate heterogeneity of the antigen or antibody, 
but the latter is less likely since specific anti-lipid A immune 
globulin shows a similar plateau effect with lipid A.
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It can be modified to inhibition of precipitation by 
preincubation of the antibodies with antigen, or hapten,prior 
to addition of antigen, to increase its sensitivity.
However, non-specific inhibition of immune precipitation was 
noticed for the highly lipophilic lipid A analogues, making 
this therefore, an unreliable assay for these studies. 
Quantitative precipitation from the practical point of view 
takes several days to develop and is not economical on sample, 
which becomes critical when only small amounts of the synthetic 
products ( i.e. glucosamine derivatives) were available.
Complement fixation is a most sensitive, reproducible and 
reliable test. However, in some cases, it has severe limitations. 
It can, for example, only be applied to immune complexes which 
fix complement, further, many antigens are anti-complementary
i.e. they fix complement in the absence of specific antibody. 
Again the classical lipid A:anti-lipid A reaction, carried 
out at concentrations below which the lipid A anti-complementary 
activity is expressed can successfully be used. However, the 
partial structures or synthetic analogues of lipid A are 
anti-complementary, so that any fixation due to genuine immune 
complex formation was obscured. Again, modification of the 
methoa by measuring the inhibition of complement fixation by 
preincubation of the antiserum with antigen, or hapten, again 
increases sensitivity. This method is a widely accepted 
serological assay and is highly sensitive. When applied to 
lipid A partial structures however, the anti-complementary 
nature of these materials presents considerable problems.
The enzyme-linked immunosorbent assay (E.L.I.S.A.) is a 
highly specific immune complex detecting system and, aa such 
is a valuable technique. The establishment of this assay requires
considerable time, and the entire assay can take up to a week
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to perform. The lipid A:anti-lipid A system can be successfully 
applied, however problems arise when attempting to substitute 
hapten or lipid A substructures as antigens, which themselves 
do not, or only poorly, attach onto walls of test tubes, or 
onto the antibody. The inhibition of E.L.I.S.A. by preincubation 
of the antiserum with the hapten prior to addition to the lipid 
A-coated tubes was jeopardised by the unavoidable presence 
of organic solvents, necessary to dissolve the fatty acids, 
and any inhibition obtained did not represent specific immune 
phenomena. This became obvious when the same material, in a 
heterologous system, that of Salmonella abortus equi with 
anti-Salmonella abortus equi showed the same pattern of 
inhibition.(page 67 )•
Passive haemolysis is the established method used for 
measuring anti-lipid A titres in trays. It is relatively easily 
adapted to a quantitative assay with estimation of lysis 
spectrophotometrically. As the lipid A analogues do not, or 
only poorly attach onto erythrocytes (partly due to poor 
solubility in the saline used for sensitising ) again 
inhibition of passive haemolysis could be measured by 
preincubation of the antiserum with the analogues. This gives 
however the problem that to ensure solubility of some materials 
the inclusion of organic solvents are necessary, which again 
inhibit antibodies non-specifically (page 67 )•
Of the various serological methods employed in the 
chapter, two namely inhibition of passive haemolysis and the 
enzyme-linked immunosorbent assay (E.L.I.S.A.) were the most 
suitable assays for use with lipid A as antigen, with inhibition 
of passive haemolysis being the most adaptable for inhibition 
with partial structures of lipid A.
Although lipid A insolubility in aqueous solutions can 
be easily circumvented, as outlined above, the problems with
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partial structures of lipid A are less easily avoided. As seen 
earlier in this chapter, their use in conjunction with small 
amounts of organic solvents seriously hindered the assays. This 
was to a large extent overcome by the subsequent incorporation 
of lipid A and its partial structures into liposomes. In this 
way, non-specific interactions were minimised and the antigenicity 
of the material in question was found to be increased.
The isolation of specific anti-lipid A antibodies using 
an immune-absorbent column of lipid A-bovine serum albumin coupled 
to erythrocytes by the aid of glutaraldehyde, enabled a one step 
separation of specific immune globulin from whole immune serum.
This method may have the disadvantage in that one may be isolating 
only the low affinity antibodies and that extensive antibody loss 
occurs during isolation. On the other hand, in order to prevent 
lipid A aggregating with proteins, non anti-lipid A immunoglobulins 
and ions present in whole immune serum, it is essential to carry 
out isolation of the specific immune globulin fraction. This 
fraction, even if not used throughout assays, should always be 
included as control to ensure specificity. Recovery of antibodies 
from affinity chromatography is notoriously low, and for anti-lipic 
A immune globulin this method shows an improved recovery on 
previous attempts. In addition, by virtue of being a continuous 
method, it could be used routinely for anti-lipid A immune globulir 
isolation.
In summary, of the various assays employed in this study, 
the inhibition of passive haemolysis semmed to be the most 
appropriate and sensitive for application to the detection of 
immunodeterminant groups in lipid A. Problems of insolubility 
of partial structures of lipid A could be overcome by incorporatior 
of these materials into liposomes, which also had the advantage 
of increasing antigenicity of the materials incorporated. Further,
interference of serum components could be avoided by the isolation 
of specific anti-lipid A antibodies from whole immune serum. 
Inhibition of passive haemolysis using materials incorporated into 
liposomes was taken as the model serological assay for further 
studies, as it has several practical advantages over the other 
systems.
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Details of Methods Outlined in this Chapter
Passive Haemolysis Test : Semi-Quantitative in Trays.
Preparation of veronal buffer (for complement-dependent assays): 
Sodium chloride (212.5 g) and sodium diethyl barbiturate 
(9.375 g) (Na barbital, Sigma), were added to 3.5 litres of 
distilled water. Diethyl barbituric acid ( 14.375 g, barbital. 
Sigma), dissolved in 250 ml of hot distilled water,was added 
to this solution. The solution was left to come to room temperaturi 
before the addition of 12.5 ml IM magnesium chloride ( 2.54 g 
MgClg, 6 HgO) and 12.5 ml of 0.3M calcium chloride (416.25 mg 
CaClg anhy.). The pH was adjusted to 7.2 and diluted to 5 litres 
with storage of this concentrated form at 4°C. Prior to use the 
solution was diluted five fold to isotonic solution (0.15 M) and 
the pH adjusted as necessary to 7.2.
Preparation of phosphate buffered saline ( for washing and 
sensitising erythrocytes);
Sodium chloride (200 g) and sodium dihydrogen phosphate (39 g) 
were dissolved in 4.8 litres water and the pH adjusted to 7.2 with 
2 M NaOH. This was made up to 5 1 with water and stored in this 
concentrated form at 4^0 until use. Prior to use it was diluted 
five fold with water and the pH adjusted to 7.2 with NaOH.
Inhibition of Passive Haemolysis ; Quantitative Test Tube Assay.
The test was carried out as follows: The inhibitor ( eg 0.5 pg 
alkali treated lipid A) was serially diluted in 50 pi veronal 
buffer and 0.1 pi whole anti-lipid A serum (haemolytic titre 16,00' 
or 4 pi immune globulin fraction (haemolytic titre 256) was added 
and incubated for 30 min at 4^0. Meanwhile lipid A coated
erythrocytes were prepared (20 pg lipid A in 500 pi erythrocyte 
sediment with 8 ml phosphate buffered saline, incubated at 37^0 
for 30 min, washed, and finally diluted in 55 ml veronal buffer ).
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Sensitised erythrocyte, suspension (1 ml) was added to the 
preincubated solution of inhibitor and antiserum and 100 \.l 
of guinea pig complement (excess) diluted 1:5 in veronal buffer, 
was added. The tubes were mixed and incubated at 37°C for one 
hour. After incubation and centrifugation the amount of lysis 
was determined by measuring the haemoglobin present in the 
supernatant from light absorption at 413 nm. Blanks lacking 
one or more components of the system were included in each set 
of tests.
Complement Fixation
Whole anti-lipid A antiserum (1 pi) was mixed with increasing 
amounts of lipid A (0.03 to 4 pg) in phosphate buffered saline 
(50 pi). Fresh guinea pig complement (7 pi of a 1:3 dilution 
in veronal buffer) was added and incubated for 1 h at 37^0 
followed by 0°C for 10 min.
For the second part of the test, sheep red blood cells were 
sensitised with anti-sheep red blood cell serum (Haemolysin or 
Amboceptor, Behringwerke) by incubation of 200 pi washed sheep 
red blood cells for 30 min with 10 pi of amboceptor in 8 ml 
phosphate buffered saline at 37^C. The sensitised erythrocytes 
were washed three times in phosphate buffered saline and 
resuspended in veronal buffer.
These amboceptor-sensitised erythrocytes (500 pi) were then 
added to the incubated tubes with 200 pi veronal buffer and 
further incubated at 37°C for one hour. Controls were carried 
out of erythrocytes with complement, veronal buffer or antiserum, 
and erythrocytes with complement and the highest amount of lipid A 
used. 100 % lysis was determined by erythrocytes in water.
The samples were centrifuged and the supernatants measured 
at 546 nm against the supernatant of a blank, ' ‘
erythrocytes but lacking complement. Erythrocytes lysed in water
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represent 100% lysis and gave an extinction of 1.35. The 
amboceptor-sensitised erythrocytes with complement (representing 
100% haemolytic activity) gave an extinction of 0.8 at 546 nm.
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CHAPTER FOUR
CHEMICAL AND SEROLOGICAL CHARACTERISATION OF LIPID A 
FRAGMENTS OBTAINED BY HYDRAZINE TREATMENT OF LIPID A.
4.1 Introduction
in the previous section of this work, the elucidation 
of the immunodominant structure of lipid A has been attempted 
by using free fatty acids, which are constituents of lipid A, 
and synthetic glucosamine-N-acyl derivatives, which resemble 
partial structures of lipid A, as inhibitors of various 
lipid A and anti-lipid A systems. It has been shown that 
these attempts were not successful; the main reason being the 
strong lipophilic properties of the products, and their water 
insolubility.
In this chapter an alternative way to isolate potential 
inhibitors will be described. An attempt will be made to 
isolate glncosamine derivatives by specific degradation of 
lipid A using graded hydrazinolysis, their synthesis otherwise 
would be most difficult to achieve. Although products similar 
to the synthetic ones are expected, it was hoped that they woulc 
still contain some of the 2-keto-3-deoxyoctonate which creates 
water solubility.
Hydrazine treatment has been used in the past by Akabori,e1
al(1952) to split peptide bonds and, since this time, for studi(
on polysaccharides to cleave the N-acyl residues of amino sugars
More recently, Gmeiner, et al (1969,1971),Gmeiner (1968) have
applied hydrazine treatment to lipopolysaccharide for the
elucidation of lipid A structure.Hydrazine treatment shows a 
time-dependent cleavage of fatty acids. It will be shown that.
—7 8—
after short time intervals, ( less than 30 min at lOO^C) the 
ester-bound fatty acids, namely lauric, myristic, palmitic and 
/3-hydroxymyristic acid are cleaved, with only partial removal 
of the amide-bound 0-hydroxymyristic acid. The removal of amide- 
boudn Brhydroxymyristic acid was found to be complete by twelve 
hours and accompanied by partial cleavage of pyrophosphate 
bridges. According to Gmeiner, et al,(1971) 5 h hydrazine 
treatment will provide fractions of different degrees of 
degradation lacking ester-bound fatty acids but only part of 
amide-bound 3-hydroxymyristic acid.The fatty acids are released ,
in the form of their hydrazides, which can be removed by acetone 
extraction. During hydrazinolysis,the; alkali-stable, but acid-labi] 
KDO-lipid A bond is retained.
4.2 Pilot Experiment of Hydrazine Treatment
Three samples of S. Minnesota R595, (250 mg each) were placed 
in ampules and dried in vacuo over phosphorus pentoxide overnight. 
To each sample, 1.25 ml of water-free hydrazine (C.Roth, Karlsruhe, 
purum grade) was added, the ampoules sealed and heated in a boiling 
water bath for 5, 10 and 20 h respectively. The gels' formed on 
cooling were washed 4 times with acetone ( 20 ml) pt 0°C (whereby 
.hydrazones .are formed followed by a single wash with ethanol (20 m3 
The preparations were dissolved in water (500 nl), ethanol added 
;(20 ml) and the mixtures allowed to precipitate at 4°C overnight. 
The precipitates were centrifuged and the sediments obtained dried 
in vacuo,(yields from 110 mg (5 h) to 103 mg (20 h)].
The preparations were analysed for KDO, phosphate, glucosamine 
and fatty acids and for their serological reactivity as inhibitors 
of the passive haemolysis system.
The results tTable 7), showed that initially the fatty acid 
esters were removed, then most of the amide-bound 3-hydroxymyristic
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Figure 16. Pathway of Degradation of thn Tdronolvsaccharide of 
Salmonella Minnesota R595 (Re) on Hydrazine Treatment.
denotes unknov/n linkage ( <^or ft )
Hydrazine : H2N-NH2
Fatty acid hydrazide : H«N-NHCO
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acids. The proportion of glucosamine, phosphate and KDO in the 
hydrazine-treated preparations remained practically constant 
After 5 h hydrazine treatment the ester-bound fatty acids-were 
effectively removed. The /3-hydroxymyristic acid in the preparation 
was reduced to 46%,,29.2% and 23.5% in the 5, 10, and 20 h hydrazine 
treated samples respectively. Correspondingly the inhibitory 
activity of the three preparations .was reduced by a factor of 
8 for the 5 h, 16 for the 10 h and >20 for the 20 h.
The amounts required for inhibition with untreated R595 were 
0.12 p.g versus 0.Ô06 for free lipid A. With regard to the 
products of degradation one should consider that they are 
heterogeneous and the subfractions undoubtedly differed in their 
solubility in aqueous solutions, and that KDO was still present.
Table 7.Chemical and Serological Analysis of S.Minnesota R595 
Glycolipid and Degradation Products obtained by Hydrazinolysis 
for 5, 10, and 20 h.
r .
Time of Glucosamine 
hydrazine (nmole/ng) 
treatment
Phosphate 
(nmole/mg)
KDO' Laurate Myristate Palmitate 
(nmole/mg)(nmole/mg)(nmole/mg)(pmole/mg)
0-Hydroxy-
myristate
(pmole/mg)
Total
fatty
acid
Inhibitory 
activity 
(ug) *
Original R595 0.72 (181) 0.82 (4%) 0.73 (25%) 0.28(8%) 0.25(8%) 0.15(6%) 0.89(31%) 100% 0.12
5'h hydrazine 1.54 
treated R595
(34%) 1.53 (6%) 1.58 (47%) 0.00(0) 0.00(0) 0.00(0) 0.41(13%) 27.6% 0.97
lO h hydrazinel.55 
treated R59 5
(34%) 1.9J (7%) 1.71 (50%) 0.00(0) 0.00(0) 0.00(0) 0.26(8%) 17.8% 1.95
20 h hydrazineO.92 (30%) 1.48 (5%) 1.12 (49%) 0.00(0) : 0.02(0) 0.00(0) 0.22(10%) i 16.2% ; 20
treated R595
material required to inhibit two haemolytic units of anti-lipid A antibodies in the inhibition of passive 
haemolysis test.
The chemical and serological tests are described on pages 37-39 inc.
The values in brackets () represents % of total recovered.
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These preliminary results indicate that hydrazine treatment 
is a suitable means of obtaining lipid A lacking ester-bound 
fatty acids, while retaining 3-hydroxymyristic acid and 
serological activity. The preparations are however, likely to 
contain a variety of structures of lipid A. If studies relating 
structure to serological reactivity are to be carried out, it 
is obviously essential to fractionate this material. A variety . 
of fractionation methods were compared for their efficiency of 
separation arid recovery, and these will be described below. i 
On analysing the products of graded hydrazinolysis by paper 
electrophoresis, it was found that a number of basic amines 
(putrescine, spermine, spermidine, etc)were present.
4.2b Paper Electrophoresis of R595 Glycolipid to Detect Amines
In order to detect the presence of amines, lipopolysaccharide 
preparations were treated with acid (5-mg lipopolysaccharide in 
50 pi 1 M HCl at 100°C for 10 min). This solution (5 pi) was 
applied together with standards of ethanolamine, lysine, glucosamir 
and glucose in the middle of an electrophoresis paper and high 
voltage electrophoresis carried out for 90 min in pyridine-acetic 
acid-water buffer by the method of Kickhofen and Warth, (196 8), 
Amino groups., were visualised with ninhydrin staining and sugars 
and polyols with Trevelyan reagent ( see pages '104 &105).
In lipopolysaccharide, lysine, 4-amino arabinose, spermine,
spermidine, cadaverine, putrescine, ethanolamine and phospho-
ethanolamine are present ( see Table 8). Estimation of these amines
was carried out on the original R595 lipopolysaccharide, after 
electrodialysis,and after further acid treatment.
Methods to Improve Lipopolysaccharide Purity (Removal of Polyamines 
4.3a Electrodialysis of R595 Lipopolysaccharide
R595 lipopolysaccharide (615 mg) was dissolved in 100 ml
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Table 8 Polyamines present In'Lipopolysaccharide.
Amine structure Rf value on electro­
phoresis (see methods)
Lysine HgN(CH^)^CH(NH^)COOH
(relative to glucosamine 
1.3
4-amino
arabinose CKOHCHim^ (CHOH) ^ 0 1.3
Spermine NH2 (CH2)2NH(CH2)^ NH(CH2)2NH22.4
Cadaverine NH2(CH2)gNH2 2.8
Spermidine NH2(CH2)2NH(CH2)^ NH2 2.9
Putrescine s(NH2 (CH2)^NH2 3.0
Ethanolamine . HOCH2CH2NH2 2.4
Phospho-
ethanolamine
P0^ 0CH2CH2NH2 0.2
Standards :
Glucosamine HOCH2CH(CHOH)gCH(NH2)CHOHO 1.0
Lysine H2N(CH2)4NH2C00H 1.3
Ethanolamine HOCH2CH2NH2 2.4
water and electrodialysed to remove cations and
amines present in the lipopolysaccharide. Eelectrodialysis 
was carried out by the method of Galanos, et al (1972) at constant 
pH (7.2) by continuously neutralising with sodium hydroxide througl 
an automatic titration apparatus. The outer, water-containing 
chambers were renewed twice an hour and continuous cooling of 
the inner chamber was carried out by cycling with ice-cooled water 
Electrodialysis was carried out at approximately 40 mA for 2-3 h 
with frequent testing of the amine content by paper electrophoresii 
as outlined above.
During electrodialysis the content of polyamines present' 
in lipopolysaccharides, namely putrescine, lysine, spermine, 
spermidine and cadaverine was significantly reduced. There was 
removal of 100% putrescine, 84% of cadaverine and spermidine, 
and 89% of spermine.This was quantified as described below.
The content of 4-amino arabinose, which is thought to be covalently 
bound, was unaffected. In addition small amounts, of to date 
unidentified ninhydrin-positive material was also removed by
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electrodialysis. Further electrodialysis did not, however, remove 
the remaining polyamines. They were removed by strong acid 
treatment in the cold,
4.3b. Quantitative Determination of Polyamines
The electrophoretically separated, ninhydrin-stained regions 
of electrodialysed R595 lipopolysaccharide ( see above) were 
eluted with ethanol. The ninhydrin positive regions were cut out 
and placed in tubes containing 2 ml 71% ethanol. After 20 min with 
occasional stirring the extinction of the extracted ninhydrin 
colour was measured at 575 nm.
4.3c Removal of the remaining traces of Polyamines from 
Electrodialysed R595
Removal of remaining amines was carried out by dissolving 
the electrodialysed lipopolysaccharide in 10 M HCl at 0*^ 0 (0.5 
ml acid per 22 mg lipopolysaccharide). The suspension was sonicated 
at O^C for 30 sec and centrifuged at 15,000 rpm for 10 min at 
0°C. The sediment was neutralised with NaOH, dialysed to remove 
salt and lyophilised. It was important to keep the temperature 
below 0°C otherwise extensive degradation of the lipopolysaccharide 
occurs. Complete removal of polyamines was checked by paper 
electrophoresis followed by ninhydrin staining.
It was noted that, after removal of the cross-linking polyamine 
the lipopolysaccharide became partially soluble in ethanol and 
acetone, probably due to extensive depolymerisation. As a 
consequence there was considerable loss of material when following 
the hydrazine-treatment the material was washed with acetone and 
ethanol to remove the fatty acid hydrazides present. Approximately 
72% of the purified lipopolysaccharide was soluble in acetone and 
ethanol, after treatment with hydrazine for 15 min this value was 
78%. Therefore washing of the hydrazine-treated preparations was 
carried out with several small volumes of acetone, avoiding ethanol
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4.3d Fractionation of Hydrazine-Treated Lipopolysaccharide.
Various fractionation methods could be applied to separate 
the hydrazine-treated electrodialysed lipopolysaccharide, depending 
on the duration of hydrazine treatment. It was found, for example 
that 20 h hydrazine-treated material, after removal of KDO, could 
be separated by paper electrophoresis, whereas 30 min hydrazine- 
treated material could not. This is probably related to the 
content of fatty acids which, in the latter case, would be high, 
causing the material to adhere to the paper and not migrate. 
According to the fractionation method selected for a sample, 
acid hydrolysis ( to remove the KDO trisaccharide) could be 
carried out prior to, or following, separation, as in the 
hydrophobic hydrazinolysates the presence of KDO may aid 
separation of components by increasing solubility in aqueous 
solutions and restricting aggregation. In any case, the fractions 
finally obtained and tested serologically, contained reduced amount: 
of KDO which as shovjn.. before ( pages 53-54) disguise the lipid 
A immunodeterminant.
Chemical and Serological Investigation of Fractions obtained after 
Hydrazinolysis for Various Periods of Time.
4.4 20 h Hydrazine Treatment 
Preparation of 20 h hydrazinolysate;
Hydrazine treatment for 20 h as described earlier, removes 
fatty acids from lipopolysaccharide, while KDO, glucosamine and 
parts of the phosphate remain present. To test whether fatty 
acids are necessary for serological interaction with anti­
lipid A antibodies, 20 h hydrazine treatment was carried out on 
lipopolysaccharide which had been electrodialysed and freed
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of amines as outlined earlier. Serological interaction with anti­
lipid A antibodies was estimated by inhibition of passive 
haemolysis ( quantitative) test ( see page 39)
The entire hydrolysate, containing phosphate, KDO and 
glucosamine showed no interaction with anti-lipid A antibodies 
(see Table 9). The small amounts of fatty acids present, probably 
represent free fatty acids not removed on washing and absorbed 
onto the material.
Fractionation by paper electrophoresis:
It was found that following acid hydrolysis ( to remove the 
KDO trisaccharide) 20 h hydrazine-treated material could be 
effectively separated by paper electrophoresis ( as outlined 
earlier). As the material lacks bound fatty acids elution of 
the components from paper represents no problem. After staining 
the electropherogram with Trevelyan reagent at least seven fractior 
could be identified ( see Figure 17, fractions lA-lc). The fractions 
were eluted with water and their purity estimated by 
're-electrophoresis. With the exception of one fraction (migrating 
to the anode and designated fraction IG) these fractions were 
found to be pure (Figure 17 b).In total, fraction lA to IF and 
G1 to G7 were obtained. All the fractions were analysed chemically; 
and serologically. As shown in Table 9 none of the fractions 
contained fatty acids and they were serologically inactive. This 
indicates that fatty acids are essential for the expression of 
serological activity in lipid A.
With these fractions it was possible to test whether the 
N-linked 3-hydroxymyristôyl residue could be replaced by an 
N-linked acetyl residue, the latter endowing the molecule with 
lipid A specificity. To test this, acétylation of the diglucosamine 
fraction (Fraction lA) was carried out and the product, containing 
acetylated amino.groups was submitted to inhibition of passive
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Figure} 17 : Paper Electrophoresis of Twenÿy-hour Hydrazine Treated 
R595 after Acid treatment.
(a) Whole Hydrolysate (b) Fractionated Hydrolysate
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Electrophoresis was carried out in pyridine-acetic acid-water pH 5.4 
(10:8:86 by volume) at 100 mA for 70 min. Standards of glucosamine
(migrating to cathode),glucose ( remaining at origin) and glucose-6- 
phosphate(migrating to anode) shown each side of the samples.
Fraction H was negative in all chemical and serological tests carried
out and was probably salt.
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Table 9. Chemical and Serological Analysis of Electrophoretically 
Separated Fraction of 20 h Hydrazine-Treated R595 Lipopolysacchari<
Fraction Glucosamine 
(GlcN)pmole 
/mg.
Phosphate
pmole/mg.
KDO
pmole/mg
GlcN;P;KDO
lA 3.81 0.35 0 1:0.1:0
IB 1.38 0.35 0 1:0.2:0
1C 2.77 0.35 0.09 1:0.1:0
ID 3.92 1.19 0.32 1:0.3:0.1
IE 2.31 0.95 0.58 1:0.4:0.2
IF 0.19 0.25 0.91 1:1.3:4.7
IGl - 0.47 0.54
1G2 0.43 0.74 1.10 1:1.7:2.6
1G3 0.14 0.45 0.94 1:3.2:6.8
1G4 0.23 0.91 0.91 1:3.9:3.9
1G5 0.12 0.28 0.56 1:2.3:4.7
1G6 0.14 0.88 1.01 1:6.1:7.1
1G7 0.21 0.92 1.60 1:4.3:7.5
No fatty acids, neither free, nor releasable by acid hydrolysis 
were detected in any of the fractions.
None of the fractions showed any interaction serologically with 
anti-lipid A antibodies in the quantitative inhibition of passive 
haemolysis test.(Concentrations up to 25 pg were used and if any 
interaction was likely this would have been detectable at this 
concentration),
haemolysis. The acetylated fraction exhibited no interaction with 
anti-lipid A antibodies, neither in the free form, nor when 
incorporated into liposomes. This suggested that the -NH-C0-CH2- 
structure, which was common to both fatty acyl residues, acetyl 
and 3-hydroxymyristoyl ,was not sufficient to provide lipid A 
specificity, i.e.the immunodominant structure of lipid A must have 
comprised a larger area.
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4.5 5 h Hydrazine Treatment of R595 Lipopolysaccharide.
Preparation of 5 h hydrazinolysâte:
Hydrazine treatment was carried out for 5 h as outlined 
earlier, using electrodialysed, amine-free lipopolysaccharide 
and followed by the removal of KDO by acid treatment. It was 
noted that following 5 h ( and 20 h) hydrazine treatment the 
degraded lipid A no longer displays precipitation during acid 
hydrolysis. Fractionation of the ensuing material was then carried 
out by separation oh a Sephadex column which, at the same time. 
Separated free KDO released on acid, hydrolysis.
Fractionation of 5 h hydrazinolysate:
Hydrazine treated R595 lipopolysaccharide, after acid . 
hydrolysis (90 mg) was fractionated on a Sephadex G15 column 
(30 cm X 2 cm, particle size 40-120 p and bed volume of 2.5-3.5 
g with void volume (determined by dextran blue) of 22 ml). 
Fractions of 1 ml were collected by elution with water and the ; 
presence of material in the fractions was tested by applying 
samples of each fraction ( 10 pi) on paper strips and staining 
with Trevelyan reagent, phosphate spray (Dittmer and Lester, 1964) 
or ninhydrin. All material was found within the first 60 ml of 
eluate. Samples of all eluates were tested on thin layer 
chromatography cellulose plates( MN cellulose 300, without 
binder) using butanol-pyridine-water (6:4:3 by vol). Serological 
inhibition of passive haemolysis in the lipid 7 system was carried 
out and chemical analysis performed. This information enabled 
the material to be pooled into five distinct fractions ( 2A-2E 
in Table 10) . •'
From all fractions the ester-bound fatty acids, lauric, 
myristic,palmitic arid 3-hydroxymyristic acid .were absent. The 
amide bound 3-hydroxymyristic acid was present in all fractions
containing serological activity. Fraction (LA contained^ practica 11:^
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Table 10. Chemical and Serological Analysis of 5 h Hydrazine- 
Treated R595 Lipopolysaccharide.
Void volume - Traction 22 Dry weight % Original R595
Fraction 2A = Fraction 24 t 25. 1.35 ro 2%
Fraction 2B - Fraction 26-28. 12.25 mg 15%
Fraction 2C = Fraction 30-37. 9.80 mg 12%
Fraction 2D = Fraction 38-43. 12.85 mg 16%
Fraction 2E = Fraction 44-48. 6.00 mg 7%
Fraction GlucosaminePliosphate 
(Mmole/mg) (pmole/mg)
KDO Laurate Myristate Palm.itate 
(pmole/mg) (pmole/mg) (pmole/m.g) (pmole/mg)
C-Hydroxy-
myristate
(pmole/mg)
Inhibitory
activity.
(Mg),
2A 0.01 (0) 0.05(1%) 0.78(97%) 0(0%) 0(0%) 0(0%) 0(0%) 5.6
2B 0.8 (39%) 0.39(3%) 0.77(50%) 0(0%) 0(0%) 0(0%) 0.13(8%) ' 0.03
2C 2.14 (54%) 1.14(4%) 2.08(54%) 0(0%) 0(0%) 0(0%) 0.03(1%) 1.83
2D 1.4 (61%) 0.84(3%) 1.99(61%) 0(0%) 0(0%) 0(0%) 0.1 (3%) 0.48
2E 1.37(47%) 0.68(4%) 1.0(45%) 0(0%) 0(0%) 0(0%) , 0.09(4%) 0.21
required to inhibit two haemolytic units of anti-lipid A antibodies in the inhibition of 
passive naemoiysis test*
Values in brackets () represent % total recovered.
only KDO and is serologically inactive. Glucosamine and phosphate 
were present in the fractions in the molar rationof 2:1 
respectively showing that acetic acid hydrolysis led to the 
cleavage of one phosphate.(The molar ratios of glucosamine to 
phosphate in the starting material, as well as in the product 
of hydrazinolysis, prior to acid hydrolysis was 1:1).
KDO was present in all fractions. Its persistence following 
acetic acid hydrolysis was unexpected. Possibly removal and 
neutralisation of hydrazine was inadequate prior to acetic acid 
hydrolysis.
From the results of serological inhibition tests it may be 
seen that fraction 2B, containing the highest proportion of 
3-hydroxymyristic acid, also showed the highest inhibitory 
activity (0.03 pg) which was comparable to that of complete 
free lipid A. Fraction 2D and 2E contain less 3-hydroxy- 
myristic acid and their inhibitory activity was lower. Fraction 
2A and 2C, showing the lowest content of 3-hydroxymyristic acid 
also exhibited the lowest inhibitory activity.
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From this preliminary experiment it became evident that 
-hydrazine treatment and subsequent acid hydrolysis yielded 
several lipid A substructures that were distinct in their 
chemical and serological reactivity. In accordance with the 
results of the previous experiment with the non-fractionated,
KDO containing hydrazinolysis products, also here, a correlation 
between serological reactivity and 3-hydroxymyristic acid content 
Was evident.
4.6.30 min Hydrazine Treatment of R595 Lipopolysaccharide.
Preparation of 30 min hydrazinolysate:
After 5 h hydrazine treatment, considerable loss of 
3-hydroxymyristic acid had already occurred. Hydrazine treatment 
for 30 min was used as a period of treatment whereby the loss 
of ester-bound fatty acids was complete and maximal /3-hydroxy­
myristic acid was retained.
Treatment of electrodialysed, amine-free lipopolysaccharide 
(R595) was qq.rried out with hydrazine at lOO^C for 30 min followed 
by washing in small volumes of acetone. The total hydrazinolysate 
(still containing k DO) was analysed for chemical composition and 
serological activity (Table 11).
Table 11. Chemical and Sorolooi.cal Analysis of P595 Lipopolysaccharide and 30 r.ir. liycraz: r.e-Treated K595.
Glucosamine Phosphate KDO Lauric acid Myristic acid Palmitic B-hydroxy- Inhibitor
(pmole/mg) (pmole/mg)(pmole/mg) (pmole/mg) (pmole/mg) Acid myristic a. activity.
(pmole/m,g) (pmole/mg) (pg)*
R595 Lipopoly- 0.59 0.60 0.68 0.30 0.22 0.15 0.93 >20
saccharide.
30 min hydraz- 0.94 1.22 0.93 0.01 0.03 0.01 0.61 15
ine treated R595
pg material required to inhibit two haemolytic units of anti-lipid A antiserom in the inhibition 
of passive haemolysis assay.
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As can be seen in this table , the ester-bound, fatty acids have 
been removed and a relatively large proportion of the amide-bound 
3-hydroxymyristic acid has been retained. The low serological 
activity of both starting material and 30 min hydrazine-treated 
lipopolysaccharide was probably due to' the presence of KDO
The mixture was fractionated without prior cleavage of KDO 
since it was hoped that KDO would increase the solubility of 
the hydrophobic substance and its presence would enable 
fractionation in an aqueous system.
Fractionation of 30 min hydrazine-treated lipopolysaccharide:
The hydrazinolysate was applied on a Sephadex G15 column 
(see page 88) and the 1 ml fractions obtained were analysed for 
chemical composition, serological interaction with anti-lipid A 
antibodies and behaviour on silica gel t.l.c plates. The eluate 
was pooled into three main fractions (3A, 3B, 3C in Table 1$, 
with fraction 3A having the highest môlecular weight and eluting 
first from the column), On these pooled fractions chemical and 
serological analysis was carried out (Table 12).
Table 12. Chemical and Serological Analysis of Fractions of 
30 min Hydrazine-Treated R595 Lipopolysaccharide.
Fraction I.Matcrial Glucosamine Phosphate KDO Laurate Myristate Palmitate .'"-Kvdroxy Inhibito:
recovered (pmole/mg) (pm.olc/mg) (pmole/mg) (pmole/mg) (pmole/mg) ,(pm61e/mg) myristic activity
(pmole/mg) (pg)*
Fraction lA 41» 1.71 1.03 0.98 0.02 0.03' 0.02 0.8: 1.5
Fraction 3B 52» 1.49 1.26 1.20 O 0.01 O 0.72 2.75
Fraction 30 4% 1.15 0.75 0.50 0.03 0.09 0.02 0.51 2.95
(The amount of free fatty acids in all cases were insignificant).
pg material required to inhibit two haemolytic units of anti-lipid A antibodies in the inhibition of passive 
haemolysis assay.
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Fraction 3C, which was obtained in relatively small amounts 
resembled the other fractions and was not studied further.
Fractions 3A and 3B, both showed distinct but low serological 
reactivity probably due to the fact that acid hydrolysis ( to 
remove KDO) had been omitted up to this point. Further 
fractionation was attempted using paper electrophoresis, but 
both fractions (also after acid hydrolysis or phosphatase 
treatment) remained at the origin. Thin layer chromatography 
on cellulose plates in butanol-pyridine-water (6:4:3 by vol) 
was also unsuccessful. Finally by applying the solvent system 
used for lipid A fractionation (chloroform-methanol-water, 140: 
45:7 by vol) on silica gel plates, better fractionations were 
obtained and it was decided to use an analogous chromatographic 
system on paper from which elution is probably easier.
KDO was first cleaved by acid hydrolysis. Acid treatment of 
fraction 3A (ninhydrin negative) produced considerable browning. 
Material was recovered from the precipitate (3A^) and the 
supernatant (3A^). Acid treatment of fraction 3B (ninhydrin 
positive) produced no colour and most material was obtained in 
the supernatant.(3B^)
These fractions (3A ,3A ,3B )were applied (2-10 mg) on 10 cm
p  S  S'
strips of Whatman 3M paper for descending chromatography:, in 
chloroform-methanol-water and elution carried out ( for details 
see page 105 ).
The eluted fractions were found to be homogeneous by small 
scale thin layer chromatography in the same solvent. The fractions 
were dried iji vacuo and chemical and serological analysis 
carried out (Table 13).
Fraction 3A^-yielded three subfractions 1,11,and III 
(Rg^^ 0.05, 0.17 amd 0.3 respectively) which did not show any
interaction with anti-lipid A antibodies and contained no 
3-hydroxymyristic acid. Similarily fraction 3A^ was separated 
ihto fractions 0.05, 0.18,0.3, 0.48, 0.71, 1.0 and 2.1)
which contained glucosamine, KDO and phosphate in varying ratios 
but no fatty acids or serological activity. Fraction 3A before 
separation however, exhibited some serological activity 
(Table 12) and contained 3-hydroxymyristic acid.,These results 
obtained with the subfractions were therefore supricing, either 
ensuing degradation occurred on acid hydrolysis, causing 3-hydroxy- 
myristic acid to be liberated in some way, or, more likely, 
the fatty acid containing material absorbed strongly onto the 
chromatography paper and under the elution conditions used, only 
glucosamine, phosphate and free KDO were removed. Another 
possibility is that the fractions realised by Trevelyan staining 
do not represent the serologically interesting fractions.
Insufficient material was recovered in the precipitate of 
fraction 3B to carry out analysis. From fraction 3B^ four 
fractions were obtained (I-IV;in Table 13), three near the 
origin (Rg^c ^.05, 0.18 and 0.3 respectively) and a further 
(IV) at 0.5. They all contained glucosamine, KDO, phosphate
and some fatty acid and exhibited some serological interaction 
with anti-lipid A antibodies. Of these fractions the content of 
3-hydroxymyristic acid (II>III>I>IV) parallels the serological 
activity, the same correlation cannot be seen with any other 
constituent, KDO, glucosamine nor phosphate.
Although little material containing serological activity 
was recovered by this method, also here, a relationship between 
serological activity and content of 3-hydroxymyristic acid is 
obvious. As sample loss was considerable on a combination of G15 
Sephadex, acid hydrolysis and descending chromatography, in the 
following experiments.chromatography was carried out directly
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Table 13. Chemical and Serological Analysis of 30 min Hydrazine- 
Treated R595, after Acid Hydrolysis and Fractionation by Paper 
Chromatography.
Fraction Revalue Glucosamine Phosphate KDO Laurate Kyristate Palr.itate .'-Hydroxy Inhibitory
((jmole/ng) (umole/mg)(^mole/ng)(wmole/mg)(umole/Rg) ( umole/mg )r^ yri state activity
(pmole/mg) (ug)*
3BgI C.05 ■ 0.12 2.02 0.27 0 O 0 0.03 6.05
3B^II 0.18 0.11 0.34 0.18 O O O 0.08 1.3
3Eg.III 0.3 0.20 0.35 0.16 O O O 0.03 2.35
3BgIV 0.49 0.09 0.2 0 0 0 0 0 >25
*pg material required to inhibit two haemolytic units of anti-lipid A antibodies in the inhibition of 
passive haemolysis assay.
on hydrazinolysate after acid hydrolysis.
4.6b Descending Chromatography of 30 min Hydrazine-Treated R595 
Lipopolysaccharide after cleavage of KDO.
Polyamine-free R595 lipopolysaccharide (pages 81-84) was 
treated with hydrazine for 30 min at 100°C by the standard 
procedure (page 90) followed by hydrolysis in 1% acetic acid 
for 90 min at 100°C ( to cleave KDO). Both supernatant (4^ ) and 
precipitate (4^ ) were lyophilised and subjected to descending 
paper chromatography in chloroform-methanol-water (140:45:7 by 
vol) for 41 h by which time sufficient separation was achieved. 
Seven fractions' were obtained from the precipitate C 4 A^ I-"VI I) 
and eight from the supernatant (4AgI-viII).
Chemical and serological analysis was carried out on these 
fractions ( Table 14). The inhibitory activity of the fractions 
was tested both directly, and following incorporationg into
liposomes (see page 39). Fraction 4A showed the largest yield
-
and contained serologically active material. It contained large 
amounts of phosphate, glucosamine and 3-hydroxymyristic acid and
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Table 14. Chemical and Serological Analysis of 30 min Hydrazine- 
Treated R595 Lipopolysaccharide after Acid Hydrolysis and 
Fractionation by Paper Chromatography.
Fraction Rf value Glucosamine Phosphate KDU •• -liydroxy- Inhibitory Activity(mç)*(Mmole/mg) (Mmole/mg) (t-mole/mg) myristate
(umole/mg)
Direct Liposome
incorporated,
4'sl 0.11 0.62 1.73 0.01 0.05 11.5 0.035
0.18 0.92 2.13 0.78 0.12 1.3 0.02
0.3 0.45 0.29 1.43 0.04 1.9 0.045
4AgIV 0.49 1.39 0.11 0.60 0.12 0.8 0.01
4AsV 0.71 0.17 0.07 0.14 0.05 0.8 0.017
4A^VI 1.0 0.76 0.01 0.82 0.07 2.7 0.007
4AgVII 1.2 0.95 0.03 0.48 0. 7.9 0.15
•ÎA^ VIII 1.5 1.26 0.23 0.81 0.04 >50 >0.5
0.11 0.94 1.26 0.15 0.09 3.0 0.035
4ApII 0.18 1.05 0.93 0.48 0.G5 0.9 0.08
4ApIII 0.3 0.53 0.51 1.04 0.03 1.0 0.16
4A IV 0.49 0.57 0.19 0.12 - 15 0.15
4A V
P 0.71 0.28 0.15 0.02 - 50 0.5
4ApVI 1.0 0.17 0.16 , 0.07 - 50 0.5
4ApVII 1.5 0.24 0.06 0.02 - 50 0.5
-Mg material required to inhibit two haemolytic unite of anti-lipid A antibodies in the inhibition of
passive haemolysis assay.
•• No other fatty acids present.
insignificant amounts of KDO.The amount required to inhibit two 
haemolytic units of anti-lipid A antibodies was 11.5 pg in solutior 
and 0.035 pg when incorporated into liposomes, emphasising the 
enhancement of antigenicity achieved by the incorporation of 
hydrophobic materials into liposomes.In the remaining fractions 
supernatant and precipitate, although yields were smaller, a 
relationship between the content of 3-hydroxymyristic acid and 
serological activity was evident. Fractions such as 4A^IV & 4AgVI 
exhibit high serological activity but are obtained in low yield. 
For this reason, in order to increase the yield of serologically 
active material containing 3-hydroxymyristic acid a milder 
hydrazinolysis procedure was applied.
4.6c 30 min Hydrazine Treatment (60^0 of R595 Lipopolysaccharide.
Preparation of 30 min hydrazinolysate:
In this experiment hydrazine treatment of R595 
lipopolysaccharide was carried out for 30 min at 60^C instead of 
100°C used previously. Hydrazinolysis at 60°C was found sufficient 
to cause cleavage of ester-bound fatty acids (P.Miihlradt, personal 
communication). In our case, it was hoped that under these milder 
conditions a higher proportion of 3-hydroxymyristic acid would 
remain bound to glucosamine.
Polyamine-free R595 lipopolysaccharide was treated with 
hydrazine at 60°C for 30 min. The resulting preparation was 
washed with acetone and treated with 1% acetic acid for one hour 
at lOO^C to cleave KDO.
Fractionation of 30 min hydrazine-treated R595 lipopolysaccharide:
The hydrazinolysate after acetic acid hydrolysis 
neutralisation was applied onto a Sephadex G15 column (29 cm x 
3 cm, exclusion volume determined by dextran blue, of 92 ml). 
Elution was carried out with distilled water at a flow rate of 
5 ml per hour and 2 ml fractions were collected. Fractions 
were characterised by applying samples on t.l.c silica gel plates ; 
(solvent chloroform-methanol-water (140:45:7 by vol)), staining 
with ninhydrin for free amino groups, iodine to detect fatty 
acids, Trevelyan to detect reducing sugars and sulphuric 
acid followed be heating at 140^0 to detect organic matter. In 
addition paper electrophoresis was performed. Finally serological 
activity was measured for each of the fractions individually.
On the basis of these analyses similarities in fractions could 
be detected and enabled them to be pooled into three main fractions 
fractions 5A,5B and 5C. The results of their chemical and 
serological analysis are given in Table 15.
Here again, the proportion of 3-hydroxymyristic acid to
/ _
Table 15. Chemical and Serological Analysis of Fractions obtained 
from R595 Lipopolysaccharide by Hydrazinolysis (30 min at 60°C) 
and Sephadex Fractionation.
Fraction Glucosamine
(unole/ng)
Phosphate
(pnole/mg)
KDO
(pmole/mg)
P-llydroxy-
myristate
(pnole/mg)
Yield
% recovered
Inhibitory Activity(ug)* 
Direct Liposome
incorporated
Original Lipid A 0.83(35%) 0.82(6%) 0.13(7%) 0.89(52%) 0.015 0.003
Fraction 5A 3.65(71%) 2.0 (7%) 0.06(1%) 0.78(21%) 57% 0.002 0.0004
Fraction 5B 3.17(66%) 2.06(17%) 0.4 (11%) 0.53(15%) 21% . 0.006 0.0012
Fraction 5C 2.22(73%) 1.3 (7%) 0.7 (3%) 0.45(16%) 21% 0.039 0.002
glucosamine paralleled the serological activity of the fractions, 
These results asserted that neither phosphate nor KDO are 
required since neither showed a similar relationship. Of the 
three fractions, fraction 5A, containing no ester-bound fatty 
acids and only traces of KDO appeared to be enriched in the 
immunodeterminant as it contains higher serological activity 
than whole lipid A. This fraction was then treated with alkaline 
phosphatase to confirm that phosphate'was not part of the 
immunodeterminant region of lipid A, and to find out whether 
it has a shielding effect.
4.7 Phosphatase Treatment of the Products of Hydrazinolysis.
In preliminary experiments it was found that the presence 
of alkaline phosphatase in lipid A and lipid A degradation 
products interfered with their inhibitory activity in the 
passive haemolysis test. Separation of the enzyme was therefore 
necessary. In order to avoid the usual problems of fractionation 
(électrophoresis or paper chromatography), immobilised enzyme 
coupled to AH Sepharose 4B was used. In this way separation of
?0"
the enzyme could be carried out by simply centrifuging the 
insoluble Sepharose particles doi.m.
4.7a Preparation of Immobilised Alkaline Phosphatase
AH Sepharose 4B (1,6-diaminohexane coupled to Sepharose 4B 
by the CnBr method, bead size 40-190 p, Pharmacia) was washed in 
0.5 M saline to remove dextran and lactose added by the 
manufacturers as preservant. To 0.3g washed Sepharose (dry 
weight) 2 pi of 25% glutaraldehyde and 50 units of Escherichia 
coli alkaline phosphatase in 2 ml 0.1. M sodium carbonate (which 
had been dialysed overnight against distilled water to remove 
ammonium sulphate) was added. The mixture was incubated for two 
hours at room temperature, then washed with glutaraldehyde- 
containing sodium carbonate buffer (0.05 M, pH 9.6) followed by 
the same buffer alone (buffer containing amino groups were avoided 
as these would compete with the coupling reaction, phosphate 
buffered saline was eliminated as phosphate release was 
eventually going to be measured). Enzyme activity in the final 
preparation was monitored with p-nitrophenyl phosphate in sodium 
carbonate buffer ( 0.05 M, pH 9.6) measuring the product, 
p-nitrophenol phosphate at 400 nm. The amount of active enzyme 
in the preparation was 15 units.
4.7b Phosphatase Treatment of Fraction 5A.
Fraction 5A (25 mg) obtained by hydrazine treatment for 
30 min at 60°C ( pages 96-97) was incubated with 500 pi of 
coupled enzyme in 1.5 ml sodium carbonate buffer (0.05 M, pH 9.6) 
and incubated at 37^C. Samples were taken at intervals of 15 min, 
30 min, 45 min, 1 h, 1 h 30 min, 2 h , 4 h, 6 h, 8 h, and 24 h 
and phosphate release followed by the determination of free 
phosphate ( as described on page 37 but omitting the initial
60 t
i
phosphat»
Total phosohate
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20 22 24 h
Hour» of phosphatase treatment
Figure 18. Release of Free Phosphate from 30 min Hydrazine- 
Treated R595 Lipopolysaccharide by Immmobilised Alkaline 
Phosphatase.
hydrolysis step with acid). After phosphatase treatment a sample 
was compared for inhibition of passive haemolysis with a control 
sample of fraction 5A that had been incubated for 24 h with 
carbonate buffer alone at 37°C. The results obtained were 0.041 pg 
0.088 pg for the control and phosphatase-treated material 
respectively. In other words neither a loss not an increase of 
inhibitory power had occurred as a result of the removal of about 
60% of the phosphate.^ Some degradation had however occurred 
as the control gave a value of 0.04 pg compared with 0.002 pg 
prior to treatment (Table 15). However, it should be noted, 
that the total phosphate content was estimated at 62 pg/mg and, 
after phosphatase treatment 20 pg/mg.i.e.,33% of the total 
phosphate still remained and was not .removed by this treatment. 
This is in agreement with the results of Gmeiner, et al, (1968) 
who observed that 40% of the phosphate was acid-labile and not 
released by monoesterase treatment ( with 14% of the phosphate 
already being removed by hydrazine treatment). The content of
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glucosamine, 3-hydroxymyristic acid and KDO remaining essentially 
unchanged.
These results indicated that at least 60% of the phosphate 
present in lipid A was not.involved in the immunodominant structure 
however--conclus ions regarding the remaining phosphate could not 
be made directly.
4.7c Further Hydrazine Treatment of Phosphatase-Treated Fraction 
5A
In order to evaluate the role of 3-hydroxymyristic acid in 
the serological activity of fraction 5A,( 30 min hydrazine-treated 
lipopolysaccharide at 60°C, acid hydrolysis and Sephadex 
fractionated) after phosphatase treatment was further treated 
with hydrazine. The decrease of the 3-hydroxymyristic acid content 
was found to correlate with a decrease in serological activity 
(Table 16)
Table 16. Effect of Further Hydrazine Treatment on 3-Hydroxymyristj 
content and Serological Activity of Phosphàtase-Treated Fraction
No further 
hydrazine, 
treatment
3-Hydroxymyristic 
acid (pmole/mg) 0.69
Further 1 h
hydrazine
treatment
0.58
Further 10 h
hydrazine
treatment
0.26
Inhibitory activity 0.002 
(pg) *
0.002 0.03
*pg material required to inhibit two haemolytic units of anti-lipic 
A antibodies in the inhibtion of passive haemolysis assay.
These results suggested that the 3-hydroxylmyristoyl substitution 
on the amino groups of the glucosamine backbone played a major role 
in the immunodominant of lipid A.
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4.8 .Summary
Hydrazine treatment carried out for 30 min.enables 
the removal of ester-bound fatty acids from lipid A yet retains 
a significant proportion of the 3-hydroxymyristic acid.
Treatment for 20 h with hydrazine,however/removes all fatty acids. 
During hydrazine treatment several products are formed in 
varying proportions and in order to study correlations between 
chemical composition and serological activity it was essential 
to fractionate the hydrazinolysate.
In this chapter several methods of fractionation were 
compared in order to obtain the best yield of serologically 
active material in the 30 min hydrazine-treated lipid A. Here 
the presence of fatty acids caused problems in paper 
chromatography and electrophoresis, where the elution of the 
fractions became difficult. The best method found was acid 
hydrolysis, to remove KDO, directly after hydrazine treatment 
and separation of the fractions on a G 15 Sephadex column. By 
this method a fraction was obtained containing 3-hydroxymyristic 
acid, but no ester-bound fatty acids and containing high 
serological activity with anti-lipid A antibodies, even higher 
than complete lipid A. This fraction, which comprises of 0.21 mole 
3-hydroxymyristic acid and about 0.55 mole phosphate per mole 
glucosamine was used for further studies.
Table 17 shows the .relationship between the substitution
of 3-hydroxymyristic acid on the glucosamine backbone of the
hydrazine treated fractions obtained in this chapter, and the
serological activity of the fractions. It should be noted that
in this table fraction 2 (A-E), 3 (A-C) and 4 (A and A ) KDO iss p
still present in varying amounts. As previous experiments showed, 
the presence of KDO disguises the immunodeterminant region. From
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Table 17 . Comparison of the ratio of 3-hvdroxvmvristic acid to 
glucosamine with serological activity of fractions obtained 
from hydrazine-treatment of R595 lipopolysaccharide in chapter 4
Fraction B-hydroxy- 
myristic acid
Inhibitory activity*(pg)
: glucosamine Direct Liposome
incorporated
2A 0.3 5.6
2B 0.2 0.03
2C - 0.02 1.83
2D . 0.07 0.4 8
2E 0.06 0.21
3A 0.5 1.5
3B . 0.48 2.75
3C 0.44 2.95
3B^I 0.28 . 6.02
3E^II 0.73. 1.3
0.14 2.3
dAgl 0.08 11.5 0.035
0.13 1.3 0.025
b.i 1.9 0.045
0.09 0.8 0.01
0.31 0.8 0.C17
0.09 2.7 0.007
4ApI 0.09 3.0 0.035
0:05 2.7 0.078
4À lii o'. 05 1.0 0.16 .
' ; 0.:, ■ 1 '
5R,’ s. 0.21 0.C02 0.0004
5B 0.17 0.006 0.0012
5C. " . 0.20 0.04 0.0019
♦ Mg-required to inhibit.two haemolytic units of antirlipid A 
antibodies in the inhibition of passive haemolysis assay.
these results it is not possible to conclude what extent of 
substitution of the glucosamine backbone with 3-hydroxymyristic 
acid is required for serological activity. It is not known 
whether a diglucosamine unit is required, or whether a 
monosaccharide is sufficient and whether a single 3-hydroxy­
myristic acid per diglucosamine unit is serologically active 
or not.
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Fraction 5 (without KDO) shows serological activity and 
contains an equivalent of 1 3-hydroxymyristic acid per 5 
glucosamine units. Each fraction 5A,5B and 5C show this 
approximate ratio. This suggests that unsubstituted glucosamine 
had not been separated from these fractions as vzas expected.
This may relate to aggregation and poor solubility in aqueous 
solutions, whic^, however, is unlikely as the diglucosamine 
backbone without fatty acids is water soluble (as shown with 
20 h hydrazine-treated material, fraction A, page 86). It may 
also^ however, relate to some portion of lipopolysaccharide 
containing unknown linkage between disaccharide units in lipid A 
which is stable to electrodialysis, acid treatment ( both to 
remove polyamine and to remove KDO), hydrazine treatment and 
phosphatase treatment.
Phosphatase treatment of fraction 5A was carried out 
using immobilised alkaline phosphatase. This was carried out 
by its conjugation via glutaraldehyde onto 1-6 amino-hexyl- 
Sepharose beads (AH Sepharose 4B)* In this way separation of the 
enzyme from the reaction mixture was simply achieved by 
centrifugation. These experiments indicated that the phosphatase- 
labile phosphate ( about 60% of the phosphate) is not required 
for serological interaction with anti-lipid A antibodies. On 
further hydrazine treatment of this material the loss of 
3-hydroxymyristic acid corresponds with the loss of serological 
activity, supporting evidence that 3-hydroxymyristic acid 
appears to play a predominant role in the serological activity 
of lipid A.
Twenty hour hydrazine treatment, whereby all fatty acids are 
removed, was also carried out on R595 lipopolysaccharide. This 
material, due to the absence of fatty acids was easily fractionated
on paper electrophoresis and the eluted material analysed. None
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of the fractions, nor the total hydrazinolysate, contained 
any fatty acids or serological activity. By this method a 
diglucosamine of lipid A was isolated. Acétylation of the 
diglucosamine did not restore serological activity indicating 
that the immunodominant structure is larger than the link 
-NH-CO-CHg.
In conclusion, 3-hydroxymyristic acid plays a predominant 
role in the serological activity of lipid A. Removal of the 
ester-bound fatty acids ( by alkali or hydrazine treatment) 
did not abolish the antigenic activity of the material. Removal 
of the phosphatase-labile phosphate groups, similarily was 
without effect on the antigenicity. The diglucosamine backbone 
alone has no activity. One fraction formed with hydrazine 
contained 3-hydroxymyristic acid and glucosamine in a molar ratio 
of 5:1 exhibited higher serological activity than complete 
lipid A,suggesting an enrichment of the immunodominant structure. 
Preliminary results suggest that this material Jaus- retained some 
biological activities of lipid A, for example mitogenic activity 
for B-lymphocytes ( see below) but it lacks toxicity, for example 
lethal toxicity for adrenalectomised mice(see below).
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4.9 tails of Methods Outlined in this Chapter.
4.9a.Paper Electrophoresis
High voltage paper electrophoresis was used in this chapter 
to separate fractions of 20 h hydrazine-treated lipopolysaccharide 
and to separate, identify and estimate the polyamines present in 
a lipopolysaccharide preparation.
The samples were applied in the middle of an electrophoresis 
paper (Schleicher and Schiill No 2043, 15 cm x 90 cm) and the 
appropriate standards applied alongside. For polyamine estimation 
standards of lysine,glucosamine and ethanolamine were used, 
whereas glucosamine, glucose-6.phosphate and glucose were used 
for the hydrazinolysate. The paper was wetted with pyridine- 
acetic acid-water (10:8:86 hf w i ?  pH 544) buffer and each end 
dipped into tanks containing the electrode and buffer. High 
voltage electrophoresis was carried out by the method of Kickhofen 
and Warth (1968) at 70 mA,1000 V for 60-90 min with cooling 
in Varsol ( immiscible with the buffer}and non-conductive) with 
temperatures maintained between 0°C and 10°C. Staining of the 
paper was carried out with ninhydrin (400 mg ninhydrin, 90 ml 
butanol, 10 ml lutidine) and the developed colour fixed with 
copper nitrate (0.02 ml conc. HNOg, saturated copper: nitrate 
and 100 ml acetone) or with Trevelyan reagent ( described below).
Trevelyan Reagent: (Trevelyan, et al, 1950)
Trevelyan reagent detects sugars and polyols and consists of 
three reagents (I,II and III).
Reagent I contains acetone (20 ml) with silver nitrate (0.1 ml 
saturated solution) and water added (dropwise) to solubilise the 
nitrate.
Reagent II contains potassium hydroxide (13 g KOH in 400 ml
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methanol) .
Reagent III is 5% sodium thiosulphate.
The dried electrophoresis paper was dipped in Reagent I, dried 
and dipped in Reagent II. Brown silver oxide was immediately 
produced, but some reducing sugars require longer at room 
temperature to develop,therefore the paper was left at this stage 
for several hours. When reduction was thought complete excess 
silver oxide was dissolved in 5% sodium thiosulphate.
' 4. 9b .Descending Chromatography
Descending paper chromatography was carried out in this chapte] 
on 30 min hydrazine treated lipopolysaccharide as a fractionation 
method.
The same was applied in a line on 10 cm strips of Whatman 
3M paper (0.33 mm thick) and descending chromatography carried 
out in chloroform-methanol-water (140*.45:7 by volume) . Standards 
of glucosamine, glucose and KDO were also run. The extent of 
separation was periodically checked by cutting paper strips^and 
' staining with Trevelyan reagent.
When separation was adequate, the paper was dried and the 
spots corresponding to Trevelyan positive regions on sample strips 
QUt out and eluted. The highly mobile, hydrophobic regions were 
eluted with chloroform-methanol-water solvent and the spots near 
the origin (hydrophilic) with water. Complete elution was ensured 
by a final wash with 20% pyridine in water and the eluates dried 
in vacuo.
-107-
CHAPTER FIVE
PRELIMINARY EXPERIMENTS ON THE BIOLOGICAL ACTIVITIES OF 
A FRACTION OF LIPID A OBTAINED BY 50 MIN HYDRAZINE TREATMENT 
OF R595 LIPOPOLYSACCHARIDE.:
5.1 Mitogenicity for B-lymphocytes.
5.la Introduction
The results obtained with the 30 min hydrazine, treated 
lipid A ( in particular fraction 5A-5C, page 97) suggested 
the involvement of 3-hydroxymyristic acid amide-linked to the 
glucosamine backbone in the immunodominant region of lipid A. 
Ester-bound fatty acids are absent therefore toxicity is 
reduced, yet immunodeterminants appear to be present as it 
interacts with anti-lipid A antibodies in the inhibition of 
passive haemolysis test.
Investigation of the serologically and chemically defined 
fractions of lipid A would be worth pursuing to evaluate its 
similarities to whole lipid A in the biological activities.
B cell mitogenicity was selected as a suitable parameter because 
being an iu vitro test it is likely to yield more information 
on the direct interaction of the above derivatives with cells. 
Another reason is that it has been shown, (Melchers and Galanos, 
unpublished) that, under certain conditions, mitogenic 
activity of lipid A is retained after alkaline hydrolysis.
When lipid A is added to spleen cell cultures extensive 
proliferation of the cells takes place. This can be measured
3
by DNA synthesis (incorporation of H Thymidine), protein
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synthesis (incorporation of labelled leucine), IgM synthesis 
or the number of plaque-forming cells (antibody producing cells 
(Andersson, et al, 1973).
The proliferation of B cells is a natural phenomena, being 
a necessary prerequisite for the development of antibody 
producing cells after antigenic stimulation. Stimulation of 
B cells with mitogens results in proliferation and subsequent 
maturation into Ig secreting plaque forming cells (PFC).
Of the two major subpopulations of lymphocytes, bone 
marrow-derived (B) and thymus derived (T), B lymphocytes alone 
are stimulated by lipopolysaccharide and lipid A to divide.
B cells transform to plasma cells and the degree of stimulation 
may be assayed by measuring the amount of radioactive DNA 
analogues incorporated into newly synthesised DNA. It has no 
effect on thymus, derived (T) lymphocytes ( P e a v y et al, 1973; 
Andersson>et al, 1973). The mitogenic principle of 
lipopolysaccharide is lipid A.
5.1b Experimental Conditions
Spleens were removed under sterile conditions from 
Balb/c male white mice, aged 2-3 months. The spleens were 
teased apart and pressed through a gauze into medium (approx
g
1 X 3,0 cells per spleen) . The cells were further dispersed 
at O^C, by drawing up and expelling the solution through a 
pasteur pipette and left to settle in medium ( RPMI 1640 with 
glutamate, Difco) for three minuteSrV whereby large particulate 
matter settled. The supernatant was decanted and centrifuged 
àt 1,000 rpm for 5 min and the sediment resuspended in RPMI 
medium. The cells were washed in this manner twice further and 
finally resuspended in complete medium consisting of 8% foetal 
calf serum (Batch U56 3601S, mycoplasma and virus screened,
Gibco), 1% penicillin and streptomycin (5,000 International
Units/ml and Smg/ml solution), 1% glutamate and 1% 1 M Hepes 
(Difco).
To enable easy counting of the cells the erythrocytes present 
were first lysed with osmotic shock. The cells were added to
0.2% sodium chloride for 30 sec followed by 1.6% saline to bring 
the solution to isotonic concentration. The cells were centrif­
uged and resuspended in the original volume (500 pi) of medium 
and diluted in Trypan blue(4:1 0.2% Trypan blue in water to 
4.25% NaCl) and the live cells (differentiated from the dead cells 
which take up Trypan blue) counted in a haemocytometer chamber. 
They were diluted to a concentration of 10 x 10^ cells per ml.
Medium (50 pi) containing lipopolysaccharide (R595), 
lipid A .(derived from R595) and fractions A and B from 30 min 
hydrazine treated lipid A (page 96) and the diglucosamine 
fraction isolated from 20 h hydrazine treated lipopolysaccharide 
(fraction A, page 86) were diluted in 50 pi RPMI 1640 in 
round-bottomed culture plates (9 x 12 wells per plate, Titertex) 
and 200 pi (equivalent to 2 x lO^cells) of spleen cell suspension 
added. These were then placed in isolated gas chambers (made 
in the workshop) and gassed with a mixture of 10% COg, 1% 0^ 
and 83% for 5 min. They were then incubated with gentle 
rocking for 48 h cit 37^0.
3
Thymidine H, 0.5 pCi (Radiochemical Centre, Amersham, 
and specific activity 2 3.7 Ci/mol) was added with mixing, the 
trays gassed for 5 min and incubated a further 24 h at 37°C.
The cells were harvested using a cell culture harvester 
(Titertex, Flow Laboratories)and rinsed with water onto glass 
fibre filters (which traps cellular material and high molecular 
weight material). The filters were dried and 0.25 ml solubiliser 
(Soluene, Packard International, Zürich) added and left overnight.
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after which time 10 ml of scintillation fluid was added 
[42 ml liquifluor. Nuclear Chicago (containing 4 g PPO and 
50 mg POPOP per litre) in 1 litre toluene]. Samples were 
counted after a minimum of three hours in the dark ( as 
impurities in the toluene produce chemiluminescence with 
components in the solubiliser, leading to spurious results).
Thymidine uptake was measured in a Nuclear Chicago counter using 
a 2 X 4 min counting time with internal and external standard 
and conversion from CPM to DPM carried out, to account for 
counting inefficiencies and machine error, with a Hewlett 
Packard 9863 tape reader and Hewlett Packard 9 810 calculator.
The results shown in Table iS were obtained.
5.1c Experimental Variations
It was found that RPMI 16 40 with glutatamate, as supplied 
by Difco, was both light susceptible and the glutamate content 
decreased on storage. Since an optimal concentration of 
glutatamate is necessary for the reproducibility of the results, 
glutamate was supplemented in this medium. Another observation 
resulting from these studies was that culturing in microtrays 
under these conditions can produce unreliable results if the 
outer row of wells was used. These rows appeared to show 
consistently poor incorporation of thymidine and microscopically 
after cell culture, were seen to be present in reduced numbers. 
Presumably cell survival in these rows was, for some reason 
such as humidity, different gaseous exchage etc, poor and these 
rows in future experiments were filled with medium alone.
The use of RPMI 1640 medium instead of Eagles (minimal 
essential medium as publisned in the original procedure (Mishell 
and Dutton, 19 67) ha.s the advantage in that cultures do not 
require feeding daily and contains calcium at the optimal • 
concentration of 0.5 mM.
Table (3.Mit.ogenigitv of Lipopolysaccharide, Linld A. 30 tr.ln or 20 h hvcrazine-treated Liraid A on ncuse 
scleen cells.
Results expressed as DPM-Standard deviation of thymidine incorporation into 2 x 10^ spleen cells incubated 
in the presence of 8% foetal calf serum.
Background (Spleen cells incubated alone - 3,077-1,055.
R595 P.595
ug Mitogen Lipopolysaccharide Lipid A
R595,30 min hyrazine treated lipid A 2Oh hydrazine
treated LipidFraction A Fraction B
25 20,514-8,916 6,776^3,662 3,382:1,437 1,337:452 2,156:967
12.5 29,023-8,072 9,058-2,562 8 ,757:1,281 6,342:1,413 1,986:423
6.25 17,557-3,241 10,925^5,325 12,343:6,038 9,147:1,365 2,162:243
3.12 7,819-7,559 9,704-4,084 7,072:2,295 6,409:1,872 2 ,280:536
1.56 1,240-314 4,390-1,499 6,500: 1,865 3,959:283 2 ,318:451
0.78 - 6,071-2,631 4 ,534:1,166 3,851:753 2 ,650:97c
0.39 - 4,995-1,616 3,923:352 3,607:924 2,646:451
0.19 - 4,686-2,998 4,518:1,565 2,818:361 2,56l:ll99
o.c-q - 4,136-2,802 3,240:701 3,409:1,112 3,217:797
.0.04 2,462-595 4 ,445:476 2 .497:372 2 ,-05:929
0.02 - - 3,099:539 . 2,08S:l,464
0.01 1,578:1,436 5S7-12-: 258:lo 1,641:50/
xlO
j. I" I"
:• i ■ i 1 j j ;  r ; ; 'i T j I L  L i '
U:E:
Lipid A
2 Z  h  r . y c r d i i n c  • ••
10 15 20 25
  ^Concentration of ir.itogen (pg)
Figure/?.Mitogenicity of Lipopolysaccharide, lipid A or
30 min hydrazine treated lipid A. Cultures containing 8%
Foetal Calf Serum-.
Hepes (N-2-hydroxypiperazine-N“2-ethansulphonic acid) 
buffer was added to the RPMI 16 40 complete medium, to 
supplement the bicarbonate-COg buffer present in RPMI, as the 
pH is critical and Hepes is the more efficient buffer. Addition 
of Hepes is not necessary when foetal calf serum is used at 
concentrations of 20% as the ',serum itself then acts as buffer. 
Due to batch variation and the controversy about its use at 
all in lymphocyte cultures, the concentration of foetal calf 
serum was kept low .and-^compensated' by the addition of Hepes. 
buffer.
3-mercaptoethanol has been added to culture medium by 
many authors ( reviewed by Schreier and Nordin, 1977), 
particularily when incubation at 37°C was not carried out with 
rocking (4-6 cycles per minute). However, there is again, 
some controversy on the stimulatory, inhibitory, or influence 
at all of 3-mercaptoethanol, therefore rocking was thought 
preferable for these experiments.
The exact mechanism by which foetal calf serum aids cells 
growth is unclear. Without foetal calf serum cell growth and 
proliferation is purported to be low, however, some authors 
claim that the background levels are lower and the mitogenic. 
index of the mitogens is higher without foetal calf serum. It 
has been suggested that impurit4.es such as lipopolysaccharide 
or colony stimulating factor may be present in the serum (Shiigi 
and Mishell, 1975; Watson and Pritchard, 1972). It should be 
noted however, that cell cultures grown in the absence of foetal 
calf serum are only free of exogenous protein.
Apart from variability in foetal calf serum it is also known 
that lipid A and probably its partial structures, aggregate 
readily with proteins in serum. Incubation with foetal calf
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serum if likely therefore to cause aggregation and subsequent 
covering of the mitogenic principles. For this reason the 
experiment was carried out under identical conditions but 
omitting foetal calf serum. The results illustrated in Table 
19 were obtained.
5.Id Results
In both sets of experiments (both with and without 
foetal calf serum) the mitogenicity of the fractions was 
approximately equivalent to that of whole lipid A and both 
were different from that observed with lipopolysaccharide.
The 20 h hydrazine-treated fraction, containing only 
glucosamine and phosphate was non-mitogenic, giving values 
within control spleen cell range.
Th results obtained in the absence of foetal calf serum 
(Table 19 and Figure 20) vary from those in the first 
experiment (Table 18 and Figure 19) in that the fractions 
A and B appear to be more mitogenic than lipid A, as lower 
amounts of these fractions were required for maximal 
stimulation in comparison with lipid A. Although the nature 
of these results are not such that conclusive evidence is 
obtained, the data represents several repetitions of the 
experiment and reproducible results were obtained. The data 
suggests that the fractions 5A.;and' 5B, despite the absence of 
ester-bound fatty acids are mitogenic, as mitogenic if not 
more, than lipid A itself. The results obtained in the absence 
of foetal calf serum suggest that the concentration of material 
required for maximal stimulation decreases in the order of 
lipid A>5B>5A, which correlates with the increase in 3-hydroxy­
myristic acid content.
At high concentrations, lipid A and the fractions show
- ± ± 4 -
tg Mltoqenicl^.y or Lipopolvsaccharido, Lioid A, 30 
•joleen cells
Results expressed as DPM-f.tandird deviation of thynidine 
in the absence of foetal calf serum
Background (Spleen cells incubated alone) - 6,137^1,091
min or 20 h hydrazine-treated Lipid A on mouse
incorporation into 2 x 10® spleen cells incubaced
ug Mitogen
R595
Lipopolysaccharide
R595. 
Lipid A ,
25 86,275-3,990 541-421
12.5 , 90,353-29,299 15,715-4,200
6.25 84,295^38,126 35,713-9,970
3.12 55,695-21,992 32,560-10,825
1.56 46,075±15,602 25,502^4,519
0.78 35,954^11,577 23,963^8,244
0.39 32,622^10,854 23,508^5,031
0.19 ,• 25,770-13,608 22,568±2,790
0.09 23,281-670 20,441^4,374
0.04 19,212-8,370 13,430-1,867
0.02 • 8,349-2,597 5,981-2,225
R595 30 min hydrazine-treated lipid A 20 h Hydrazine 
A Fraction 3 treatisj lipiUA
480-79 426-295 8,056-1,062
634-495 723-280 9,633-1,475
673-110 .7,595^5,456 7,931-279
10,952-3,682 25,703-3,672 • 5,245-172
29,970-1,647 " 29,322^6,280 5,889-640
17,729^3,800 18,189-5,453 5,242-8
10,034-2,142 11,712±4,579 5,868-453
6,584±1,554 11,226-3,855 5,745-291
7,826-1,670 9,154-2,945 5,140-672
5,466-3,324 7,874^3,813 5,245-381
2,739-975 3,882^1,759 5,471-1,467
DPM
x l O
90
i R597 Llporiolysaccharlde
1-H!'T
60
40
on B
20
25201510
Concentration of mitogen (ug)
Figurelo.Mitoqenicity of 7.^ipopolvsaccharide ^ Lipid A or 
30 min hvdrazine treated lipid A. Cultures in the absence
of Foetal Calf Serum.
-JL13-
suppressed thymidine incorporation to below control values. 
From both sets of experiments it appears that this inhibitory 
effect is greater in the fraction than in lipid A itself.
It could be suggested that two mechanisms are involved, a 
higher mitogenicity, and a higher 'toxicity' for cells which 
could explain why, at higher concentrations, lipid A shows 
greater mitogenicity than the fractions.
5.le Conclusions
The results enable one to make several suggestions about 
the mitogenic principle of lipid A. One possibility is that 
3-hydroxymyristic acid, attached to a glucosamine backbone is 
the minimal mitogenic principle of lipid A. Scanty evidence 
for this is provided. Another possibility is that the mitogenic 
principle resides within the backbone which is maintained in 
the presence of 3-hydroxymyristic acid and lost when 
configurational changes associated with the loss of this 
fatty acid occur. Removal of the ester-bound fatty acids in 
this model may make the site more accessible. Other 
possible interpretations being that 3-hydroxymyristic acid may 
just cause a suitable lipophilic enviroment suitable for 
lymphocytic membrane attachment, or may just function to : 
stabilise the receptor site.
Naturally in conjunction with the serological and 
chemical analyses carried out on these fractions, the most 
favourable hypothesis would be that 3-hydroxymyristic acid 
linked to glucosamine is the structure responsible for 
antibody recognition and mitogenicity.
5.2 Preliminary Results cn Toxicity
The fractions of lipid A obtained by 30 min hydrazine-
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treatment of R595 lipopolysaccharide (fractions 5A-5C, page 
97) was tested in adrenalectomised mice as, as outlined on 
page 10, removal of the adrenal glands significantly increases 
the sensitivity of these animals to endotoxin. Fraction 5B 
was tested in a single experiment and administered in doses 
of 1 |jg, 0.5 pg and 0.25 pg in 200 p i  phosphate buffered saline 
into groups of six Balb/c male mice aged 2-3 months. At the 
highest dosage (1 pg) all the mice died. With 0.5 p g ,  0.25 pg 
or phosphate buffered saline ( control) all mice in each group 
survived. The lethal toxicity (LD^^) of lipid A in these mice 
is approximately 0.02 pg, ie the toxicity is 30 times lower 
of Fraction 5B than lipid A.
This indicates that the toxicity of fraction 5B containing 
3-hydroxymyristic acid, phosphate and glucosamine, but no 
ester-bound fatty acids is significantly reduced compared to 
whole lipid A. However this is data from a single preliminary 
experiment and would require extensive repetitions with larger 
groups of animals before any conclusive evidence is obtained.
“11 /•
CHAPTFR SIX 
D Ï S C I J S S i n î ,
Lipid A is the toxic principle of lipopolvsaccharides 
present in the cell wall of Gram-negative bacteria. Like intact 
lipopolysaccharide its administration in experimental 
animals leads to the development of multiple biological 
activities that may be both harmful and beneficiary to the 
organism.
The mechanism of action of lipid A is still unknown. Further 
it is not known which distinct chemical groups and configuration 
are responsible for the different biological activities.
The purpose of this study was to identify the immunodominant 
structures in lipid A to which anti-lipid A antibodies are 
directed.
6.1 Heterogeneity of Lipid A
The heterogeneity of lipid A has been well documented. It 
was initially considered here whether lipid A could be separated 
into antigenically active and inactive fractions. Various . 
fractions, about ten, were separated by thin layer chromatograph] 
No distinct differences in their overall chemical composition 
however could be detected, although, differences in solubility 
were observed. On the other hand, all fractions isolated were 
antigenically active showing no significant differences in 
their ability to inhibit the lipid A-anti-lipid A passive 
haemolysis system. It v/as therefore concluded that in a given ; 
lipid A preparation the serological determinants are distributed 
more or less evenly among the various subfractions.
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6.2 Serological Assays of Lipid A
Lipid A, by virtue of its hydrophobic nature causes many 
problems in serological assays by its tendency to aggregate 
and associate with ions, proteins, lipids and phospholipids 
present in serum. A considerable reduction of the aggregation 
was achieved by the complete removal of amines and ions by 
electrodialysis (Galanos, et al, 1972) and acid treatment, and 
the conversion into a uniform salt form, the triethylamine 
form. In order to reduce the amount of compounds in serum with 
which lipid A normally combines the specific anti-lipid A 
immunoglobulin fraction was isolated from whole immiune serum. 
This was achieved by the use of an immunoadsorbent column where 
lipid A-bovine serum albumin was coupled to erythrocytes by 
glutaraldehyde with further stabilisation with glutaraldehyde 
followed by dispersion in cellulose.
In order to study the serological interaction of lipid A 
or lipid A degradation products with anti-lipid A antibodies 
a sensitive and specific immunological assay system was sought 
for. Various test systems were investigated and adapted for 
this purpose like the complement fixation test, immune 
precipitation, the semi-quantitative and quantitative passive 
haemolysis assay and the enzyme-linked immunosorbent assay (E.L.
I.S.A.). Furthermore the corresponding inhibition tests were
investigated for their suitability.
In the past, passive haemolysis of lipid A-coated
erythrocytes with anti-lipid A and complement, carried out in 
haemagglutination plates, has been the main means of identifying 
and quantitating anti-lipid A antibodies. This semi-quantitative 
method was modified in this study to increase its sensitivity 
and to enable its use for haptens which lack the ability to
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absorb onto erythrocytes, by introducing a pre-incubation stage 
of antigen with antiserum and measuring inhibition of haemolysis 
Complement fixation, although a sensitive assay, requiring 
small amounts of antiserum and antigen, had the disadvantage 
that lipid A and its derivatives, both synthetic and natural, 
showed innate anti-complementary activity. Immune precipitation 
was found to lack the required degree of specificity since 
high precipitation was also observed with non immune serum.
The enzyme—linked immunosorbent assay (E.L.I.S.A.) proved 
to be a highly sensitive assay and will doubtlessly be a 
useful immunological tool in future. Large scale E.L.I.S.A. 
systems have already been set up for routine screening of sera 
(Ruitenberg, et al, 1977). However, the poor solubility of the 
partial structures of lipid A in the buffers used prevented 
their investigation as inhibitors.
In all assay systems, even after eliminating factors such 
as non-specific aggregation with proteins and ions present in 
the antigen or antiserum, the same fundamental problems,' 
arising from the lipophilic properties of the antigenic material 
used again occurred. To overcome this problem the incorporation 
of these hydrophobic materials into artificial membranes or 
liposomes, was studied.Incorporation into liposomes facilitated 
the retention of the substances within a fixed membrane structur 
which itself was completely inert. It was hoped that when in 
the lipid membrane of the liposomes, the lipid A preparations 
would be prevented from forming aggregates and be evenly 
distributed, ib the liposome. The fact that this was so, was 
shown by the finding that the antigenicity of all substances 
was enhanced ( about ten fold).
6.3 Degradation of Lipid A to obtain Partial Structures
With the above mentioned antigen-antibody sytsems at
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hand, with isolated anti-lipid A immune globulin and with 
liposomes carrying hydrophilic inhibitors in their membranes, 
it was attempted to isolate lipid A fragments carrying 
different degrees of degradation and then tested for their 
ability to inhibit the serological assays. The non involvement 
of ester-bound fatty acids was shown by short periods of 
hydrazine treatment (30-45 min) whereupon ester-bound fatty 
acids were cleaved but amide-bound fatty acids, to a large extent 
were retained within the molecule. VThen the hydrazinolysate 
was fractionated on a Sephadex column, individual fractions 
were isolated which contained glucosamine, phosphate and 
3-hydroxymyristic acid in varying proportions. Fractions high 
in glucosamine to 3-hydroxymyristic acid ratio showed 
serological interaction with anti-lipid A antibodies, equivalent 
to, or greater than, the original unmodified lipid A. Removal 
of the labile phosphate by phosphatase (part of the phosphate 
could not be eliminated) did not significantly reduce the 
serological activity, suggesting that labile phosphate is not 
involved in the immunodominant region. Further treatment of 
the isolated fractions with hydrazine resulted in the decrease 
of serological activity which corresponded to a decrease in 
the glucosamine to 3-hydroxymyristic acid ratio. Removal of 
all 3-hydroxymyristic acid by 20 hour hydrazine treatment 
resulted in the complete loss of serological activity. This 
fraction was found to contain only glucosamine and phosphate.
In order to investigate whether mere substitution of the free 
amino groups restored serological activity, N-acetylation of 
the free amino groups of the glucosamine disaccharide backbone 
obtained by 20 hour hydrazine^ treatment was carried out. The 
N-acetylated structure showed no serological reactivity
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suggesting that mere substitution of the free amino groups 
of the disaccharide by acetyl moieties was insufficient 
for activity.
On the basis of the studies carried out here, a partial 
structure of lipid A was postulated as possible immunodominants, 
it vzas based on the structure of a diglucosamine backbone with
3-hydroxymyristic acid substitutions at either aminorgroup 
or both (Figure 21). Phosphate groups seem to be unimportant.
>0, OH
CH,CHjOH
■0.
■o'
Digtucosamine backbone 
substituted with two amide i 
bound JB-Hydroxy myristic
Diglucosamine substituted 
with one, C2.,J0-Hydroxy 
myristic ocid
CH,
CH,
Diglucosamine substituted 
with one, C2,^-Hydroxy 
myristic ccid
Figure 21. Degradation products of lipid A as likely 
Immunodominant structures of Lipid A.
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In all lipid antigens studied so far, there is no direct 
evidence that fatty acids are involved in the iirjnuno de terminant. 
From the evidence obtained in this study, the minimal structure 
involved in the immunodeterminant structure was the diglucosamin* 
backbone carrying 3-hydroxymyristic acid. Whether the presence 
of a disaccharide is essential or whether a 3-hydroxymyristic 
acid substituted monosaccharide is sufficient could not be 
elucidated.Synthetic myristoyl-D-glucosamine sugars showed no 
interaction in the inhibition of passive haemolysis assay.
This thesis was concerned mainly with one aspect of lipid 
A, namely its reaction with anti-lipid A antibodies. After 
avoiding or overcoming the problems associated with its 
hydrophobicity a suitable assay system was developed which 
enabled partial structures of lipid: A- to be! tested. Ester-bound 
fatty acids were shown here to be uninvolved in the 
immunodeterminant region,whereas amide-bound 3-hydroxymyristic 
acid appears to play a major role.
Ester-bound fatty acids are however, involved in the 
toxicity ^  vivo of lipid A. Their removal results in non-toxic 
preparations. On the other hand, it was found that de-esterified 
preparations retain some vitro effects, for which mitogenicit 
for B-lymphocytes was a suitable model. The results on 30 min 
hydrazine-treated lipid A indicated that 3-hydroxymyristic acid 
substituted diglucosamine is still mitogenic for B-lymphocytes.
In conclusion, these studies on the immunodeterminant 
structure of lipid A suggest a definite role of 3-hydroxymyristi 
substituting the glucosamine backbone in the antigenic site 
of lipid A. Preliminary results suggest that this structure 
also carries mitogenic activity vitro but little vivo 
toxicity. As a result of these findings it will now be possible
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to synthesise simplified analogues of these structures in 
order to identify minimal structural requirements for i£i vitro 
activities of lipid A, i.e. antigenicity and mitogenicity.
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